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Bovine Pneumonic pasteurellosis, commonly called shipping fever, is a severe, 
acute respiratory disease of cattle. The disease results in death losses, 
decreased animal performance and productivity, as well as other medical and 
labor costs that cause a tremendous economic impact on the stocker and feeder 
cattle industry. In fact, it has been estimated that shipping fever results in an 
estimated one billion dollars in losses to the North American beef cattle industry 
annually (Whitely et al., 1992).
The pathogenesis of shipping fever is relatively complex and is often referred to 
as the bovine respiratory disease complex. Initially, there is impairment of the 
host’s innate respiratory defense mechanisms by one or a combination of 
factors or stressors. The stressors include weaning, changes in feed, 
transportation over long distances, overcrowding, dehydration, fatigue, abrupt 
changes in weather/temperature, and perhaps most-importantly, respiratory 
viral infections. Following impairment of the respiratory defense mechanisms, 
secondary bacterial infections result in a severe bronchopneumonia that 
produce most of the morbidity and mortality associated with the disease. The 
organism most frequently and consistently isolated from the lungs of cattle that 
have died with shipping fever has been Mannheimia hemolytica biotype A, 
serotype 1(A1). M. hemolytica produces numerous virulence factors to aid 
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establishment of disease, and arguably, the most important of these virulence 
factors is leukotoxin.
Leukotoxin is a heat-labile exotoxin that has been shown to be specific for 
ruminant leukocytes. Leukotoxin acts in a dose dependent manner to cause 
death of the leukocytes by either apoptosis (low dose) or cytolysis (high dose). 
Therefore, leukotoxin severely impairs the ability of the pulmonary host defenses 
as it results in destruction of the immune cells recruited to remove the 
proliferating Mannheimia. Recently, it has been shown that leukotoxin acts by 
specific binding to the cell surface receptor LFA-1 (CD11a/CD18). LFA-1 is 
important in the process of extravasation of leukocytes and is comprised of an 
alpha (CD11) and beta (CD18) subunit that form a heterodimer. What is not 
certain is which specific subunit is critical for leukotoxin binding, CD11a alone, 
CD18 alone, or a combination of both? A better understanding of the relationship 
between LKT and LFA-1 would prove beneficial to the treatment and 
management of bovine pneumonic pasteurellosis.
Background
I. Host Respiratory Defense Mechanisms:
An understanding of pulmonary defense mechanisms is critical before discussing 
how they are impaired in the establishment of disease. The normal pulmonary 
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defense mechanisms can be divided based upon their anatomic location of either 
air-conducting regions or gas exchange regions of the respiratory tract. A 
comprehensive review of the pulmonary defense mechanisms is beyond the 
scope of this thesis. The following discussion summarizes the major components 
and has been summarized from Immunobiology, 5th Edition by Charles A. 
Janeway, Jr., Paul Travers, Mark Walport, and Mark J. Shlomchik; and How the 
Immune System Works, 2nd Edition by Lauren Sompayrac.
A) Air conducting regions:
1) Nasal turbinates: The nasal turbinates play an important role by creating 
an enormous turbulence of airflow that results in the forcing of particles 
larger than 10 µm onto the surface of the nasal mucosa. Here the particles 
become entrapped and are removed by mucociliary escalator.
2) Bifurcation of major airways: The particles that are between 2-10 µm are 
trapped by this bifurcation whereas particles less than 2 µm may to settle 
in the bronchioles and the gaseous exchange regions. 
3) Mucociliary clearance: The mucociliary blanket is the most important 
defense mechanism of the conductive system. This blanket is a complex, 
multi-laminar mucus layer that moves along rhythmically beating cilia. The 
mucus plays an important role in trapping the inhaled particles. Toxic 
soluble gases can also mix with the mucus blanket thereby lowering the 
concentration of the toxic gases that reach the lower lung.
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4) Bronchial Associated Lymphoid Tissue (BALT): BALT is located at the 
bifurcation of the bronchi and bronchioles. BALT plays an important role in 
on-site immunologic processing of the inhaled antigens. BALT traps the 
pathogens and presents the antigens derived from them to the circulating 
lymphocytes, thus inducing adaptive immune responses. In the absence 
of pathogens/antigens, BALT provides sustaining signals to the circulating 
lymphocytes, so that they continue to survive and recirculate until they 
encounter their specific antigen.      
5) Humoral Immunity: Humoral Immunity includes IgA antibodies that guard
the respiratory mucosal surfaces as they are very effective against 
mucosal invaders including bacteria. The dimeric structure of IgA enables 
them to cross-link or agglutinate pathogens together into clumps that are 
large enough to be swept out of the body with the mucus.
B) Gas Exchange Regions: 
1) Alveolar Macrophages (AMs): Alveolar Macrophages derived from the 
blood monocytes play an active role in phagocytosis and killing of bacteria 
without inciting an inflammatory response. AMs leave the alveoli and 
migrate to the transitional region where they are exported by the 
mucociliary elevator and phagocytose entrapped particles (larger than 10 
µm).
2) IgG antibodies play an important role in complement cascade activation 
and binding the surface of pathogens for opsonization by alveolar 
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macrophages. IgG plays a role in helping natural killer (NK) cells to 
destroy the pathogens by ‘antibody-dependent cellular cytotoxicity’ 
(ADCC) mechanisms. In ADCC, the antibody specifically binds both to the 
pathogen through its antigen binding regions and to the Fc receptors on 
the surface of NK cells. Thus, the IgG antibody actually forms a bridge 
between the pathogen and the NK cell facilitating the destruction of the 
pathogen by the NK cell. 
3) Pulmonary Intravascular Macrophages (PIMs): PIMs are a resident cell 
population, which in structure and function resemble mature macrophages 
of the mononuclear phagocyte system (MPS) in various domestic species, 
particularly the ruminants. PIMs are involved in lipid metabolism and are 
the major source of vasoactive substances, which significantly influence 
both the dynamics of pulmonary circulation and the surfactant turnover of 
the ruminant lung (Atwal et al., 1989). PIMs are also invoved in efficiently 
clearing blood-borne particles.
II. Factors/Stressors that Impair Respiratory Defenses:
Stressors that lead to the impairment of pulmonary defense mechanisms (Frank 
G.H. et al., 1986) include:
A) Environmental Stressors like heat, cold, wind, rain, dust, toxic fumes, etc. 
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B) Nutritional stressors like ration changes, irregular feeding schedules, 
inadequate access to clean water, etc. 
C) Management stressors like weaning, transportation, comingling, 
overcrowding, etc.
Stress in general causes immunosuppression that promotes colonization by 
bacteria like Mannheimia hemolytica (Filion et al., 1984). Some physical 
stressors that have been associated with pneumonic pasteurellosis cause 
increased plasma cortisol concentration, increased glucocorticoids, reduced 
phagocytic and bactericidal capabilities of macrophages, inhibition of antibody 
responses and lymphocyte and neutrophil functions (Roth et al., 1984). These 
provide an opportunity for respiratory viruses to establish themselves in the 
respiratory tract. The damage caused to the respiratory tract by the respiratory 
viruses further impairs pulmonary defense mechanisms. Because of the 
important role played by the respiratory viruses in the full-fledged establishment 
of bacterial pneumonia, viral infections deserve special consideration.
III. Viral Infections and Mycoplasma: 
Although bacterial pneumonia secondary to Mannheimia hemolytica appears to 
be the cause of death in most acute cases of BRD, the role of viruses in this 
disease complex cannot be underestimated. Viral infections alone usually cause
self-limiting disease; however, respiratory viruses modulate the host-defense 
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mechanisms and alter the upper respiratory tract (URT) and lung environment, 
such that bacterial infection can occur. Viral infection has been shown to 
influence adherence and colonization of bacteria by altering the host cell surface 
membrane receptors and the microenvironment where bacterial attachment 
occurs (Babiuk et al., 1995). This is followed by damage and necrosis of the URT 
epithelium, causing loss of cilia or alteration of mucus and ciliated cell function, 
compromising the mucociliary clearance of bacteria. This in turn, leads to 
increased colonization and bacterial growth. There are important viruses that 
directly affect the bovine respiratory tract and have long been established as 
important components in the BRD complex. 
1) Bovine herpes virus 1 or infectious bovine rhinotracheitis virus (IBRV) is a 
ubiquitous respiratory virus that usually affects cattle older than 6 months. 
Respiratory infection varies in severity depending upon the strain involved, and 
the symptoms can range from inapparent or mild clinical signs to severe disease 
(usually as a result of secondary bacterial pneumonia) with about 10% mortality 
(Kapil and Basaraba, 1997). Infection with IBRV causes necrosis of the URT 
epithelium that in turn compromises mucociliary clearance of bacteria, leading to 
increased colonization, multiplication, and ultimately bronchopneumonia. 
2) Bovine parainfluenza 3 virus (PI3V) is the most consistently isolated virus in
cases of BRD (Toth et al., 1988). This ubiquitous paramyxovirus replicates within 
ciliated epithelium of the URT as well as alveolar epithelium and macrophages, 
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and alone, causes only mild clinical signs in young calves (2-8 months) and 
occasionally yearling cattle (Bryson et al., 1979). Experimental calves exposed to 
an aerosol of PI3V demonstrated reduced pulmonary bacterial clearance of 
Mannheimia hemolytica particularly at day 7 and day 11 post-exposure (Lopez et 
al., 1976). This inhibition of pulmonary clearance caused by the virus may be a 
key factor in the pathogenesis of pneumonic pasteurellosis. Furthermore, as with 
IBRV, PI3V appears to cause a pre-disposition to bacterial pneumonia secondary
to virus mediated alterations in bactericidal capacity of macrophages, decreased 
phagocytosis of bacteria, and immunosuppression (Martin et al., 1989).
3) Bovine respiratory syncytial virus (BRSV) commonly infects young healthy 
cattle causing an asymptomatic or mild acute respiratory disease. In newly 
weaned calves, BRSV causes a severe necrotizing bronchiolitis and 
bronchointerstitial pneumonia that can result in death (Scott et al., 1994). BRSV 
infections mainly occur as annual winter outbreaks affecting young calves during 
the first 6–9 months of life. The virus infects respiratory epithelium in both the 
upper and lower respiratory tract (Morrison et al., 1999; Viuff et al., 1996; and 
Viuff et al., 2002). The clinical response to BRSV varies from sub-clinical to 
severe, acute pneumonia (Kimman et al., 1988). The virus first replicates in the 
epithelial cells in the upper part of the respiratory tract, and later, around day 6 
post infection (p.i.), in the lower respiratory tract (Viuff et al., 2002). Enhanced 
respiratory rate and coughing can persist for a longer time, probably due to 
airway damage or secondary bacterial infections (Tjornehoj et al., 2003). The 
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cytotoxic T-lymphocyte response seems to be important in immune protection of 
calves as it is found that the depletion of cytotoxic T-cells (CD8+) before 
experimental BRSV infection results in prolonged nasal shedding of virus and 
more extensive replication of virus in the lungs (Gaddum et al., 1996; Taylor et 
al., 1995). BRSV is also known to impair certain functions of alveolar 
macrophages. Specifically, non-opsonized phagocytosis was reported to 
decrease during the early post-inoculation period in a calf model (Olchowy et al., 
1994). Fc-receptor mediated phagocytosis was either unchanged or slightly 
increased following BRSV inoculation. A variable effect was noticed on AM 
phagosome lysosome fusion with increased fusion activity on days 2 through 5, 7 
and 12, but reduced activity on days 6 and 10 post-inoculation (Olchowy et al., 
1994). Alterations in AM function are the most critical impairment of the host 
defense mechanisms within the gas exchange regions of the lung.
4) Bovine Viral Diarrhea Virus (BVDV): Respiratory tract infections from
opportunistic bacteria may occur in unthrifty cattle persistently infected with BVD
(Peterhans et al., 2003). BVDV can be recovered with high frequency from 
pneumonic lungs of cattle. Initial replication of this virus occurs in the respiratory 
tract and tonsils (Bolin et al., 1992) and it is believed that certain strains of this 
virus have the capacity of producing a mild respiratory tract disease. However, 
there is little direct experimental evidence that establishes BVDV as a primary 
pathogen causing pneumonia. Experimental evidence also supports the 
conclusion that BVDV enhances the incidence and severity of respiratory tract 
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disease caused by Mannheimia hemolytica (Potgieter et al., 1997). AMs 
recovered from experimentally infected calves showed significant reduction in Fc-
receptor (FcR) and complement receptor (C3R) expression, phagocytosis and 
microbicidal activity, and the production of neutrophil chemotactic factors (Welsh 
et al., 1995). However, macrophages exposed to the virus in vitro, only showed 
significantly reduced FcR and C3R expression and phagocytic activity (Welsh et 
al., 1995). These results demonstrate that BVDV can reduce local immune 
defense mechanisms in the lung following infection by the respiratory route, and 
in conjunction with the other immunosuppressive agents, BVDV would favor a 
pre-disposing role for the virus in the pathogenesis of respiratory disease in 
cattle. 
5) Mycoplasmas are another group of organisms that may contribute to 
pneumonic pasteurellosis. Although mycoplasmas are commonly isolated from 
the upper and lower respiratory tracts of cattle with or without clinical pneumonia, 
their role in BRD is difficult to evaluate. Mycoplasma bovis and Mycoplasma 
dispar, the two most common isolates, potentially may be important underlying 
factors playing a role in BRD because of their immunosuppressive and 
subclinical pneumonia causing capacity as illustrated by feedlot calves with 
clinical signs of respiratory disease (Allen et al., 1992). The lung lesion caused 
by M. bovis is partly due to the host's immune response, presumably contributing 
to the control of the infection, and that the B-lymphocytes infiltrating the lung are 
11
a major source of the local and systemic IgG antibody that is detected after 
infection (Howard et al., 1986).
IV. Development of Bronchopneumonia: 
The impairment of pulmonary defenses as a result of complex interactions 
between the stressors and viral agents can lead to the establishment of bacterial 
pneumonia. The most distinctive feature of this pneumonia is the development of 
inflammation at the bronchiolar-alveolar junctions. As a result, it is usually known 
as bronchopneumonia.  The following summary of the pertinent features of the 
development and characteristics of bronchopneumonia has been obtained from 
Pathology of Domestic Animals, Volume 2, 3rd Edition by K.V.F. Jubb, Peter C. 
Kennedy, and Nigel Palmer. The vulnerability of bronchiolar-alveolar junctions to 
the damage caused by M. hemolytica is mainly due to three factors. First, these 
junctions serve as a major site for the deposition of particles (0.5-3.0 µm in 
diameter) that are capable of reaching deep lung. As a result, most bacteria 
settle at this site. Secondly, the bronchiolar epithelium is devoid of a mucus 
blanket and a resident macrophage population. Lastly, the cellular 
(macrophages) and the non-cellular materials cleared from large volumes of 
alveolar parenchyma clog the narrow lumen of the bronchioles. The clearance of 
the clogged bronchiolar lumen is further hampered by the lack of collateral 
ventilation in this region, a unique feature of ruminant lungs. Therefore, the 
absence of as well the failure of these defense mechanisms to halt the 
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unchecked colonization and growth of bacterial populations such as M. 
hemolytica, Pasteurella multocida, Hemophilus somnus, and Corynebacterium 
pyogenes that normally colonize the URT, into the lower airways subsequently 
results in variable degrees of inflammation of the lung tissue.  This ultimately 
leads to the precipitation of bronchopneumonia.
The bronchopneumonia is characteristically cranioventral in distribution (Picture 
1A). The cranioventral nature of the bronchopneumonia is mainly attributed to the 
increased deposition of particles in the cranial regions due to shorter and more 
abruptly branching airways, or defenses that are more easily compromised, or 
both. Other factors that might contribute to this cranioventral pattern include the 
gravitational influences that impede the clearance of the cranioventral regions, 
and the smaller size of ventral airspaces and their greater vulnerability to 
collapse.
The bronchopneumonia involves a patchy distribution of inflammation that 
generally involves more than one lobe. This pattern results from an initial 
infection of bronchi and bronchioles that extends into the adjacent alveoli. In 
addition to the extensive reddish-black to grayish-brown cranioventral regions of 
consolidation with prominent gelatinous thickening of interlobular septa (Picture 
1B) and fibrinous pleuritis, areas of coagulation necrosis are a characteristic 
feature. They usually contain large numbers of bacteria, particularly at the 
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periphery adjacent to the compacted debris of inflammatory cells that forms the 
white boundary seen grossly.
Microscopically, the bronchioles and the adjacent alveoli are filled with 
neutrophils (Picture 1C & D), and an admixture of variable amounts of cell debris, 
mucus, fibrin, and macrophages. The bronchiolar epithelium appears to be 
hyperplastic or necrotic depending upon the severity of the lesion. Also, few foci 
of inflammation can also be seen in the peribronchiolar connective tissue. Alveoli 
peripheral to the severely inflamed bronchiolar regions are partially atelectatic 
and contain variable amounts of edematous or serofibrinous exudate, 
erythrocytes, and macrophages.  
The bronchopneumonia that becomes confluent, fulminating or highly 
aggressive, and tends to involve major portion or the entire lobe is termed as 
lobar pneumonia. Lobar pneumonia is the result of overwhelming spread of 
inflammation throughout the lung without reference to bronchiolar regions. 
Grossly, the interlobular septa appear prominently distended with serofibrinous 
exudate along with the development of irregular, discrete zones of necrosis with 
swollen pale borders. Microscopically, the vessels passing through the severely 
inflamed regions tend to develop vasculitis with occasional formation of thrombi. 
A common feature to most lobar pneumonias is massive proliferation of bacteria 
within the developing necrotic foci.
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Picture 1
A. Lobar Pneumonia (in situ) B. Lobar Pneumonia (Cross Section)
Macroscopic view of lung lesions in Bovine Pneumonic Pasteurellosis
(Photographs provided by Dr. Anthony Confer)
  C                                           D
Microscopic view of lung lesions in Bovine Pneumonic Pasteurellosis
(Photographs provided by Dr. Jerry Ritchey)
20X 40X
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V. Mannheimia hemolytica: 
The etiology that is usually associated with bovine pneumonic pasteurellosis is 
Mannheimia (Pasteurella) hemolytica biotype A, serotype 1 (A1) (Confer et al., 
1988; Frank et al., 1988). Genetic analysis (16S rRNA sequencing and DNA-
DNA hybridizations) of Pasteurella organisms has resulted in a new classification 
for several strains of the organism commonly involved in respiratory tract disease 
in cattle. Mannheimia hemolytica is the new taxonomic classification for
Pasteurella hemolytica, as suggested on the basis of results from a recently 
published study (Angen et al., 1999).
According to Kim Alan Brogden (June, 2000), of the USDA-ARS National Animal 
Disease Center, historically, two biotypes have been recognized for the taxon
Pasteurella hemolytica: biotype A, and biotype T. Biotype A isolates ferment 
arabinose whereas biotype T isolates ferment trehalose. The trehalose-positive 
isolates were found to represent a distinct species (Pasteurella trehalosi that
currently contains serovars 3, 4, 10, and 15). The trehalose-negative organisms 
were found to represent the distinct genus (Mannheimia) with five species 
(Mannheimia glucosida, Mannheimia granulomatis, Mannheimia hemolytica, 
Mannheimia ruminalis, and Mannheimia varigena). The organisms now classified 
as Mannheimia hemolytica contain serovars 1, 2, 5-9, 12-14, 16, and 17.
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Adlam and Rutter (1989) describe M. hemolytica is a gram-negative,  non-motile, 
non-spore forming, small coccobacillus or rod (0.2 µm to 2.0 µm) that is a 
member of the family Pasteurellaceae. The family Pasteurellaceae includes 
many pathogenic bacteria of the genera Pasteurella, Hemophillus and
Actinobacillus: These organisms have worldwide distribution and are capable of 
affecting a broad range of species, including humans, domestic animals, lower 
mammals and birds. Most Pasteurellae are commensals on the mucous 
membranes of the URT and intestinal tract of wild and domestic animals. M. 
hemolytica is a facultative anaerobe and its culture characteristics include 
oxidase and catalase positivity, with varying ability to cause hemolysis. The 
organism can grow in unenriched media; however, the growth is enhanced with 
supplements of fetal bovine serum or blood. Bacterial colonies are usually 
obvious by 24 hrs, and are characterized by moderately-sized, round grayish, 
hemolytic colonies with a sweet odor. 
Mannheimia hemolytica biotype A, serotype 1 and 2 (A1 and A2) are normally 
present in low numbers in the nasal passage of clinically healthy cattle, and the 
organisms that are predominantly isolated are biotype A, serotype 2 (A2). These 
organisms are rarely associated with shipping fever (Frank, 1979; 1988). 
However, when healthy cattle are stressed secondary to viral infections and/or 
changes in feed, nutritional deficiencies, weaning, transportation over long 
distances, overcrowding, dampness, dehydration, injury, fatigue, or inclement
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weather temperature drop leads to the precipitation of pneumonic pasteurellosis. 
The main event between immunosuppression of the animal and the precipitation 
of pneumonia involves the journey of commensal M. hemolytica biotype A, 
serotype 1 (A1) from the upper (nasal passage) to the lower respiratory tract, 
ultimately leading to the colonization of lungs. As a result, the organism most 
frequently and consistently isolated from the lungs of cattle that have died with 
shipping fever has been M. hemolytica biotype A, serotype 1 (A1). 
VI. Bacterial Factors Associated with Virulence:
During the last decade, advances in molecular biological techniques have helped 
unravel and identify many virulence factors of bacterial pathogens including 
those of M. hemolytica. Even so, there are still many gaps in the understanding 
of the pathogenic mechanisms of this organism. So far, the most important 
virulence factors identified for M. hemolytica include fimbriae/pili, capsule, LPS, 
outer membrane proteins, heat-shock proteins, o-sialoglycoprotease, 
neuraminidase, and arguably the most important of all – leukotoxin.
Colonization of the URT mucous membrane seems to be the first and foremost 
step towards the establishment of M. hemolytica. However, not much information 
is available on the mechanisms of adhesion and colonization of the bovine URT 
by M. hemolytica. It is not clear whether M. hemolytica adheres to the URT 
mucosa or whether it remains in the mucus layer without adhering (Confer et al., 
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1995). Two major factors that lead to the colonization of the URT by gram-
negative bacteria are alterations in the mucociliary apparatus and the loss of 
fibronectin, an adhesive glycoprotein from epithelial cell surfaces (Pavia et al., 
1987). Loss of fibronectin, which exposes receptors on cells and permits binding 
of gram-negative bacteria, appears to be a key event favoring colonization of the 
human URT (Proctor et al., 1987; Woods et al., 1987). In cases of human URT
infections, adherence could potentially take place through pili. The presence of 
pili in M. hemolytica has only been demonstrated by one group of researchers, 
and has not been verified by other independent groups (Gonzalez and 
Maheshwaran, 1993; Confer et al., 1995). Hence, the expression of pili and their 
role in adherence of M. hemolytica remains unclear. Outer membrane proteins 
(OMPs) and capsular polysaccharide preparations of M. hemolytica have been 
shown to adhere to bovine tracheal mucus (Botcher et al., 1993; Confer et al., 
1995). In addition, neuraminidase produced by M. hemolytica can cleave bovine 
mucin and could be a potential factor in promoting adherence of the organism to 
mucous membranes (Botcher et al., 1993) (Confer, 1995). 
Fimbriae/Pili:
Bacteria employ a number of mechanisms through which they attach to the host 
tissues. One of the better-studied mechanisms involves the use of rod-shaped 
protein structures called fimbriae. The existence of fimbrial structures on M. 
hemolytica in vivo and in vitro has been reported. Two types of fimbriae have 
been demonstrated on M. hemolytica A1 grown in vitro (Morck et al., 1987). A
19
larger, 12 nm diameter, rigid structure, and smaller, 5 nm diameter flexible 
structure were seen using transmission electron microscopy (TEM). Pulmonary 
lavage fluid recovered from an experimentally infected calf also revealed fimbriae 
of about 10 nm diameter on the bacterial cells (Morck et al., 1988). Also, linear 
structures suggestive of fimbriae were seen adherent to the tracheal epithelium 
in a naturally infected calf (Morck et al., 1989). Potter and coworkers (1988)
purified the larger, rigid fimbriae by mechanical shearing and centrifugation from 
M. hemolytica A1, and characterized their subunit molecular weight as 35-kDa by 
SDS-PAGE and immunoblotting with monoclonal antibodies raised against native 
fimbriae. All further electron microscopic studies using similar procedures have 
failed to demonstrate the presence of fimbriae on the surface of Mannheimia 
hemolytica (Richards A, unpublished data, 1989; Murphy G, unpublished data, 
1992; Gonzalez and Maheswaran, 1993). 
Capsule:
The capsule serves a number of protective functions, including a possible role in 
adherence to mucus or epithelial cell surfaces. The main function of the capsule 
is to protect the bacteria from the host’s inflammatory response, including 
complement activation and phagocyte-mediated killing.
Capsules are known to be very poor immunogens, especially those with sialic 
acid or hyaluronic acid residues (Lifely et al., 1985). Many members of the 
pathogenic family Pasteurellaceae, including M. hemolytica, are encapsulated.
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The capsule is produced during the logarithmic phase of growth (Odendaal et al., 
1999). Those purified M. hemolytica capsule has been analyzed and found to be 
acidic, negatively charged, with high molecular weight polysaccharides, 
composed of repeating units of two or three sugars or amino sugars (Wilson et 
al., 1992). Although, the capsule of M. hemolytica is not a good immunogen, a 
high serum antibody response to purified M. hemolytica A1 capsular 
polysaccharide (Brogden et al., 1989) correlates with resistance to transthoracic 
challenge with virulent M. hemolytica A1 in cattle (Confer et al., 1989). Whether
or not the capsule of M. hemolytica plays any role in URT adherence has yet to 
be determined.
Endotoxin/Lipopolysaccharide (LPS):
By weight, 12-25% of the bacterium is composed of LPS (Rimsay et al., 1981; 
Keiss et al., 1964) and the majority of the LPS is of the smooth type (Emau et al., 
1987). LPS interacts with leukocytes, macrophages/monocytes, endothelium, 
hepatocytes, adreno-cortical cells, RBCs and platelets and localizes on the cell 
membrane, and/or in the cytosol, mitochondria, lysosomes, endoplasmic 
reticulum and the nucleus (Spitzer, 1986). LPS enters the cells by first binding 
with LPS binding protein (LBP) to form LPS-LBP complex. This complex 
subsequently interacts with LPS’s specific receptor, CD14, via the core 
polysaccharide or by insertion into the cell membranes via the lipid A portion of 
the molecule (Morrison et al., 1981; Haeffner-Cavaillon et al., 1985). LPS also 
binds to low and high-density lipoproteins in plasma and a variety of cell types 
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may ingest LPS via receptors for these proteins (Tobias et al., 1985). LPS may 
directly interact with the mitochondrial outer membrane and destroy the 
membrane’s proton gradient leading to the loss of oxidative glycolysis. This leads
to anaerobic glycolysis, production of lactic acid and oxygen radicals, breakdown 
of the lysosomal membrane and ultimately leading to cell death (Guo et al., 
1994).
Bovine pulmonary artery endothelium is sensitive to the stimulatory and toxic 
effects of endotoxin (Gartner et al., 1988). It has been documented that the 
exposure of bovine endothelial cultures to LPS causes dose dependent shape 
changes, cell retraction, increased cell membrane permeability and pyknosis 
(Meyrick et al., 1986). These changes are accompanied by decreased synthesis 
of DNA, RNA and protein (Gartner et al., 1988).   
Endotoxin entering the lung via the airway or blood can directly interact with 
alveolar and pulmonary intravascular macrophages leading to their activation,
both directly and indirectly, via complement activation (Morrison et al., 1978, 
1981). In response, these macrophages produce a variety of proinflammatory 
(Issekutz et al., 1987; Roubin et al., 1985), procoagulant (Tipping et al., 1988; 
Nakstad et al., 1987), and reactive oxygen intermediates (ROIs) and proteases 
(Werb et al., 1983; Dyer et al., 1985). The cytokines (IL-1, TNFα) and lipid 
mediators (PAF, LTB4, LTC4 and LTD4) are major factors in the inflammatory 
response. IL-1 and TNFα are chemotactic for neutrophils, monocytes and 
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lymphocytes and they activate neutrophils to degranulate and produce ROIs
(Billingham et al., 1987). Highly purified IL-1 is not directly chemotactic, but does 
stimulate degranulation and the respiratory burst in neutrophils. These cytokines 
also increase the expression of adhesion molecules such as intercellular 
adhesion molecule-1 (ICAM-1) on endothelial cell surfaces and the family of 
CD18 adhesion molecules on neutrophil cell surfaces (Billingham et al., 1987). 
These adhesion molecules are essential for neutrophil’s endothelial adhesion 
and emigration into the lung parenchyma (alveoli). IL-1 and TNFα can also act in 
an autocrine manner to activate macrophages (Billingham et al., 1987).
Outer Membrane Proteins:
Outer membrane proteins have been shown to be involved in in vivo growth of M. 
hemolytica. Of these, iron-regulated outer membrane proteins (IROMPs) appear 
to be the most important. For in vivo growth in an iron-restricted environment 
such as lung tissue, bacteria produce IROMPs that function to sequester and 
transport iron into the bacterial cell. Three IROMPs have been discovered in M. 
hemolytica grown under iron-restricted conditions. Antibodies to these IROMPs 
occur in convalescent serum from calves recovering from M. hemolytica
infection. Also, iron is required in the media for optimal growth and production of 
leukotoxin (Gentry et al., 1986). These studies suggest a role for IROMPs for in 
vivo growth of M. hemolytica, and may be important in protective immunity 
against shipping fever.
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In the last five years, outer membrane proteins (OMPs) of M. haemolytica have 
always been, but recognized in the last 10 years as potential antigens for 
acquired immunity. Antibodies to M. hemolytica OMPs are associated with 
resistance to M. hemolytica challenge in cattle. Many of the OMPs are exposed 
on the surface of M. haemolytica S1 strains and, henceforth, are readily 
recognized by leukocytes and circulating antibodies (Pandher et al., 1999). In a 
recent study, Confer et al. (2003) demonstrated that the addition of a 
recombinant OMP, rPlpE to commercial M. hemolytica vaccines could greatly 
enhance vaccine efficacy. They also reported a significant reduction in
complement-mediated killing of M. hemolytica in bovine immune serum depleted 
of anti-PlpE antibodies through adsorption with PlpE. This suggests that 
antibodies against PlpE may contribute to host defense against the bacterium.
Heat Shock Proteins: 
Heat shock proteins (HSPs) are also known as stress proteins. As the name 
suggests, heat shock proteins provide protection to the bacterium from stressful 
conditions encountered within the host. These proteins are induced when the 
bacteria are subjected to different types of environmental stresses like heat, cold 
or oxygen deprivation. One major function of HSPs is that they act as 
chaperones to make sure that newly synthesized cell proteins are folded into the 
right shape and in the right place under these conditions. Enhanced production of 
an approximately 54-kDa protein was detected in heat-shocked cultures of M. 
hemolytica. The heat-shock-inducible protein of M. hemolytica cross-reacted with 
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antibodies to 60-kDa heat-shock proteins of Mycobacterium tuberculosis, 
Chlamydia, and Escherichia coli GroEL (Mosier et al., 1998). Results of this
study suggest that the 54-kDa heat-shock protein may be a growth-condition-
dependent immunogen that is one component of resistance to pneumonic 
pasteurellosis.
O-sialoglycoprotease: 
O-sialoglycoprotease facilitates the adherence of M. hemolytica to the cell 
surface. O-sialoglycoprotease also has the ability to cleave fibronectin from the 
cell surface in vitro (Woods et al., 1987), thus exposing the surface receptors. It 
has been observed that brief trypsinization of bovine nasal epithelium leads to 
increased adherence of M. hemolytica A1. O-sialoglycoprotease may also 
specifically cleave and inactivate secretory IgA (Kooney et al., 1984).
Neuraminidase:
M. hemolytica produces neuraminidase and neutral proteases that may alter the 
microenvironment and enhance its ability to colonize the URT (Frank et al., 1981; 
Tabatabai et al., 1981; Otulakowski et al., 1983). Neuraminidase is a virulence 
factor associated with several gram-negative and gram-positive bacteria (Milligan 
et al., 1978; Wadstrom et al., 1978). In an in vitro study, M. hemolytica A1 
produces larger amounts of this enzyme than the less virulent A2 strain 
(Tabatabai et al., 1981). Neuraminidase has been shown to decrease the gel-
forming capacity and viscosity of bovine respiratory mucus (Milligan et al., 1978; 
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Wadstrom et al., 1978). This may lead to decreased clearance efficiency of the 
mucociliary apparatus and permit bacteria to penetrate the mucus blanket and 
approach the epithelium. 
Leukotoxin:
Leukotoxin is a heat-labile protein exotoxin that is oxygen stable, non-dialyzable, 
hemolytic, water-soluble, and is produced by M. hemolytica during the 
logarithmic phase of growth (Baluyut et al., 1981). Leukotoxin has a molecular 
weight of 101-105 kDa when determined by SDS-PAGE (Lo et al., 1987; Chang 
et al., 1987). It is highly immunogenic and antiserum raised to the 105-kDa 
protein neutralizes its leukotoxic activity (Chang et al., 1987). Cattle with high 
leukotoxin antibody titers have higher survival rates in natural and experimental 
cases of pneumonic pasteurellosis than those with low antibody titers (Confer et 
al., 1988). 
Leukotoxin has been shown to be specific for ruminant leukocytes: neutrophils, 
lymphocytes, and monocytes/macrophages (Shewen et al., 1982). Leukotoxin 
acts by forming pores in the cell membrane that permit the influx of calcium into 
cells (Gerbig et al., 1989; Clinkenbeard et al., 1989). Neutrophils and 
macrophages respond to leukotoxin by cell swelling, organelle and cytoplasmic 
membrane disruption and chromatolysis. The same changes occur in alveolar 
macrophages when leukotoxin is instilled into the lung (Whiteley et al., 1991). 
The lytic effect of leukotoxin appears to be dependent on the presence of calcium 
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in the medium (Gerbig et al., 1989; Clinkenbeard et al., 1989). Calcium influx into 
the cells may induce the activation of phospholipases that release platelet 
activating factor and arachidonic acid with subsequent formation of chemotactic 
and vasoactive lipids. These events further lead to the induction of 
proinflammatory cytokines IL-1 and TNF-α. Uncontrolled calcium influx causes 
the cell membranes to loose their integrity as a result of continued phospholipase 
degradation. This calcium influx leads to the activation followed by cell death. 
VII. Leukotoxin: Mode of Action and Effects
As leukotoxin is arguably the most important virulence factor, it deserves special 
consideration. LKT is a member of RTX (Repeats in Toxins) family. According to 
their target cell specificity, RTX are divided into two classes, leukotoxins and 
hemolysins. Leukotoxins act on leukocytes only. Hemolysins lyse erythrocytes as 
well as various nucleated cell types. Nucleotide sequence alignments indicate 
that M. hemolytica LKT, E.Coli hemolysin (HlyA), Actinobacillus 
actinomycetemcomitans leukotoxin, and Actinobacillus pleuropneumoniae
hemolysin are nearly identical (Lally et al., 1989). LKT plays an important role in 
the pathogenesis of bovine pneumonic pasteurellosis. It specifically acts on 
ruminant leukocytes (Clinkenbeard and Upton, 1991) including cattle, sheep,
goats, deer, siaga antelope and sable antelope (Confer et al., 1990). Non-
ruminants leukocytes are resistant to the action of LKT (Confer et al., 1990).
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Molecular separation of LKT and LPS is difficult (Yoo et al., 1995). Czuprynski 
and Welsh (1995) proposed that LPS might be necessary for maximal production 
of some RTX family toxins and might act as a cofactor in some biological effects 
of these toxins. Toxicity is initiated by the binding of LKT to the target cells. It is 
generally believed that LKT binding specificity determines LKT target cell 
specificity. Flow cytometric analysis showed that LKT binds to bovine leukocytes 
but not to pig or human leukocytes (Brown et al., 1997). However, it has been 
documented that LKT can bind to Raji cells, which are a human lymphocytic cell 
line (Sun et al., 1999). LKT does not bind to protease K-treated bovine 
neutrophils, which indicates that some proteins on the cell surface are involved in 
the binding process (Brown et al., 1997). Lally and coworkers (1997) found that 
antibodies against β2-integrin inhibited E.coli hemolysin (HlyA) activity and 
nonsusceptible K562 cells transfected with β2 integrin (human CD11a/CD18 or 
LFA-1) became susceptible to HlyA and A. actinomycetemcomitans leukotoxin. 
Therefore, they proposed that the β2 integrin, LFA-1, acts as a receptor for A.
actinomycetemcomitans leukotoxin and HlyA.
After binding to the target cells, RTX family toxins change their conformation 
(Moayeri and Welch, 1997) and insert into target cell membranes to form 
transmembrane pores (Murphy et al., 1995). Some LKT mutants without the 
transmembrane pore-forming domain can still bind to BL3 (bovine lymphoma cell 
line) cells and act as competitors of wild-type LKT (Cruz et al., 1990). The initial 
pore size produced by LKT is slightly less than 0.9 nm (Clinkenbeard et al., 
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1989). This pore formation causes rapid leakage of intracellular potassium and 
results in subsequent cell swelling (Clinkenbeard et al., 1989). The above events 
are not dependent on the presence of extracellular calcium (Clinkenbeard et al., 
1989); however, LKT can induce an extracellular calcium influx through a 
voltage-gated channel (Hsuan et al., 1998). As a result, the intracellular calcium 
concentration increases from a resting concentration of 0.1µM to 1.5 µM. The 
increased intracellular calcium levels induced by LKT may signal the activation of 
phospholipase, apoptosis, release of cytokines, degranulation and production of 
ROIs, and ultimately lysis of the cell (Cudd et al., 1999).
Clarke and co-workers (1994) demonstrated that M. hemolytica increases the 
production of leukotriene B4 (LTB4) in a tissue chamber model. Clinkenbeard 
and co-workers (1994) demonstrated that LKT induces LTB4 production from 
bovine neutrophils in vitro. Wang and co-workers (1998) found that LKT activates 
phospholipase A2 (PLA2), which then cleaves eicosanoids from membrane 
phospholipids in BL3 cells. Eicosanoids may be converted into LTB4 by the 
action of 5-lipoxygenase. 
LKT also induces cytokine synthesis and release. Yoo and co-workers (1995) 
documented that purified LKT induces expression of IL-1 and TNF-α and this can 
be detected by northern blot. They also demonstrated that 0.5 U/ml LKT is 
required to induce bovine alveolar macrophages (BAMs) to transcribe TNF-α and 
IL-1β mRNA. At higher concentration of LKT, BAMs were lysed. Czuprynski and 
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co-workers (1995) demonstrated that heat-treated LKT or LKT treated with 
neutralizing mAb lost the ability to induce cytolysis but continued to induce 
cytokine release. LKT also induces intracellular calcium elevation in LKT 
susceptible bovine alveolar macrophages (BAM), and subsequently induces the 
expression of IL-1β, TNF-α and IL-8. Tyrosine kinase inhibitor blocks LKT 
induced expression of these cytokines in BAMs (Hsuan et al., 1999).
Following incubation with sub-lytic doses of LKT, bovine leukocytes demonstrate 
morphologic changes that are consistent with apoptosis such as cytoplasmic 
membrane blebbing, chromatin condensation and margination (Stevens and 
Czuprynski, 1996). Wang et al., 1998, and Sun et al., 1999 reported that LKT 
induced BL3 cells to undergo internucleosomal DNA fragmentation that is 
regarded as the hallmark of apoptosis. Sub-lytic doses of LKT also induce 
degranulation and generation of ROIs from neutrophils. Release of enzymes 
from neutrophil’s cytoplasmic granules and ROIs damage the tissues and play an 
important role in pathogenesis of bovine pneumonic pasteurellosis. High doses of 
LKT lyse the target cells. Experiments have shown that large plasma membrane 
defects develop on target cells resulting in the leakage of large intracellular 
molecules such as lactate dehydrogenase (LDH) (Clinkenbeard et al., 1989). 
Deletion of LKT gene from M. hemolytica results in the deletion of leukolytic 
ability of bacterial culture supernatant (Murphy et al., 1995). 
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M. hemolytica LKT exhibits low level of non species-specific hemolytic activity 
(Murphy et al., 1995). This hemolytic activity of LKT is much less efficient than its 
leukolytic activity. The ability of LKT to cause hemolysis suggests that it is able to 
bind to erythrocytes by a mechanism independent of its species-specific 
leukolytic activity. LKT binding to erythrocytes may not be mediated by a protein 
receptor. Instead, binding to erythrocytes may involve direct interaction of LKT 
with membrane phospholipids. The exact mechanism remains to be elucidated.
Li and Clinkenbeard (1999) have documented CD18 is the species-specific 
receptor of M. hemolytica LKT. The LKT binding domains of bovine CD18 are 
apparently species-specific, because M. hemolytica LKT does not recognize 
human CD18. Pro-LKT could recognize or bind to the bovine CD18 receptor, 
suggesting that LKT acylation, which is necessary for its activity, is not required 
for target cell specific binding (Fedorova and Highlander, 1997).
VIII. Summary and Statement of Research Problem:
Identification of the host cell receptor(s) of M. hemolytica LKT is a prerequisite for 
understanding the pathogenesis of bovine pneumonic pasteurellosis. Significant 
progress has been made towards identifying the receptor for the RTX family 
toxins. Lally and coworkers (1997) identified the ß2 integrin LFA-1 as the receptor 
for the leukotoxin of A. actinomycetemcomitans and the HylA of E.coli.
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Subsequently, ß2 integrins have been identified as the receptors for the LKT of 
M. hemolytica (Ambagala et al., 1999; Jeyaseelan et al., 2000; Li et al., 1999; 
Wang et al., 1998). ß2 integrins are leukocyte-specific integrins, which have a 
common ß subunit, CD18 that noncovalently associates with three distinct α
chains, CD11a, CD11b, and CD11c, to give rise to three different ß2 integrins: 
CD11a/CD18 (LFA-1), CD11b/CD18 (Mac-1), and CD11c/CD18 (CR4), 
respectively. 
The most important role of ß2 integrins is to mediate the intercellular adhesion 
essential for normal immune and inflammatory responses (Springer et al., 1990). 
The ß2 integrins promote intercellular adhesion by binding with complementary 
molecules present on other immune cells or endothelium. The best characterized 
ligand for a ß2 integrin, CD11a/CD18 (LFA-1) is a distinct protein of the 
immunoglobulin superfamily, intercellular adhesion molecule-1 (ICAM-1) (Marlin 
et al., 1987; Rothlein et al., 1986). ICAM-1 is expressed by endothelial cells, 
lymphocytes, and tissue macrophages following their stimulation by certain 
cytokines, such as TNFα, IL-1, and IL-8 (Dustin et al., 1986). As the ligand for 
LFA-1, ICAM-1 functions in the trafficking of leukocytes between the peripheral 
blood and the sites of inflammation in tissues. In addition to cell-cell adhesion, 
other immune functions such as phagocytosis and chemotaxis are also 
dependent on ß2 integrins (Arnaout et al., 1990). ß2 integrins have also been 
found to promote apoptosis in human leukocytes (Walzog et al., 1997), an 
observation that correlates with the apoptosis induced by low dose of M. 
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hemolytica leukotoxin (Stevens et al., 1996). The disease, leukocyte adhesion 
deficiency (LAD), resulting from the loss of ß2 integrin surface expression, 
emphasizes the importance of ß2 integrins in normal immunological function. LAD 
has been reported in both humans and cattle (Arnaout et al., 1990). LAD patients 
are highly susceptible to bacterial pathogens and suffer from recurrent infections. 
In humans and cattle, the disease results from mutations in the gene encoding 
CD18 (Kishimoto et al., 1989; Tajima et al., 1993). Specifically, the molecular 
basis of bovine leukocyte adhesion deficiency (BLAD) is a single point mutation 
(adenine to guanine) at position 383 of the CD18 gene that causes an aspartic 
acid to glycine substitution at amino acid 128 in the glycoprotein. This mutation 
lies within a large extracellular region that is highly conserved across the CD18 
subunits of cattle, human and mouse (Kishimoto et al., 1989; Shuster et al., 
1992). BLAD calves have been used in conjunction with the M. hemolytica
pneumonia model to study neutrophil infiltration patterns in the lung (Ackermann 
et al., 1999; Ackermann et al., 1996). These studies concluded that CD18 is 
important for the emigration of neutrophils through bronchi and bronchioles. 
While there is agreement that ß2 integrins are the receptors for M. hemolytica
leukotoxin, there is no consensus as to which subunit (or both) serves as the 
specific receptor for the LKT. Previous studies have revealed that LKT binds to 
all three ß2 integrins, suggesting that the ß subunit CD18, which is common to all 
three ß2 integrins, is the subunit that mediates LKT-induced cytolysis of bovine 
leukocytes. However, the possibility of the CD11 subunits contributing to the 
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binding of the LKT cannot yet be ruled out. Previous studies have revealed that 
Candida albicans binds to the CD11b/CD18 on human leukocytes (Forsyth et al., 
1998). Although in the absence of CD18, the CD11b subunit alone binds C. 
albicans, a single point mutation in the CD18 abolishes the binding of the fungus 
to CD11b/CD18. Therefore, it could be extrapolated that even if M. hemolytica
LKT binds only to CD18, the CD11 subunit might contribute to the appropriate 
conformation needed for the binding of the LKT. 
On the basis of the previous work by Ambagala et al., 1999; Jeyaseelan et al., 
2000, Lally et al., 1997, and Li et al., 1999, we hypothesized that LKT binding 
and cytotoxicity is mediated by bovine CD18 subunit alone. Further, the 
irrefutable identification of CD18 as the LKT receptor could be made only by 
recombinant expression of CD18 and CD11 subunits, individually or together on 
LKT-non-susceptible cells, and thereby rendering them susceptible to LKT 




Blood Collection: Blood was collected for peripheral blood mononuclear 
cells (PBMCs) to serve as a source of RNA for the amplification of the integrin 
coding sequences. 15 ml of whole blood was collected using jugular puncture 
from a clinically healthy heifer in a sodium citrate tube. 
Collection of PBMCs from blood: 
Whole bovine blood was centrifuged @ 2000 rpm for 7 min and plasma 
removed and discarded. The cellular fraction was resuspended 2X the 
original volume in saline and layered on 12 ml of ficoll (HistopaqueR, Sigma), 
which was subsequently centrifuged at 800g for 40 min without brake.  The 
PBMC layer was removed with a quick draw pipette gun. The collected 
PBMCs were washed twice with 1X phosphate-buffered saline (PBS) at 2000 
rpm for 5 min each at room temperature.
Stimulation of PBMCs with Concanavalin A: The pelleted cells were 
suspended in 3 ml of RPMI-1640 medium (Gibco, Invitrogen) supplemented 
with 10% heat inactivated fetal bovine serum (FBS, Cat # 35-011-CV, 
Mediatech, Cellgro, VA).  Live cells were counted by trypan blue dye 
exclusion and the cell count was adjusted to 1X106 cells/ml and 5 ml of the 
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cell suspension (5 X 106 cells) were plated (Sigma) in a 6-well plate with 10 
µg/ml Concanavalin A for 4 hrs at 37 °C in the incubator.
RNA isolation: Total cellular RNA was isolated from stimulated bovine 
PBMCs using a guanidine thiocyanate technique. Briefly, 1 ml of RNA Stat-60 
(TEL-TEST, INC., Friendswood, TX) was added to the pelleted cells (5X106) 
and the cells were lysed by pipetting up and down multiple times. 200 µl of 
chloroform was added to the cell lysate and the RNA was subsequently 
isolated according to the kit instructions, quantified with a spectrophotometer, 
and adjusted to 100 ng/µl with nuclease free water.
Reverse Transcription (RT) of mRNA into cDNA: The bovine RNA sample 
was reverse transcribed into cDNA in one large RT reaction. Briefly, 6 µg of 
RNA (60µl of RNA suspension) was combined with 500 pmol of Oligo dT, 
heated to 72 °C for 7 min, and subsequently chilled on ice. This was further 
adjusted with additional reagents to the following conditions: 5X RT buffer (50 
mM Tris-HCL pH 8.3, 3 mM MgCl2, 75 mM KCl), 20 mM DTT, 0.5 mM dNTP, 
1 U/ml RNAsin, 10 U/µl Superscript RT (Invitrogen) in a total volume of 150 µl 
made up with diethyl pyrocarbonate (DEPC)-treated water. The RT mixture 
was incubated at 45 °C for 60 min, heat-inactivated at 94 °C for 10 min, and 
quickly chilled on ice. Commercially available human leukocyte cDNA was 
procured from Clontech, BD Biosciences.
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Primer Design: Bovine CD18 as well as human CD18 and CD11a sense and 
antisense primers were designed from previously published sequences in 
Genbank. HindIII ( AAGCTT) and XbaI (TCTAGA) restriction sites were 
incorporated in the sense and antisense primers for directional cloning, 
respectively.
     Bovine CD18: (Sequence published by Shuster et al., 1992) 
    Sense-5’- ATATAAGCTTGGGGACATGCTGCGCCAG- 3’
         Antisense-5’-CAATTCTAGAGCACCCCTAACTCTCGGCAAACTTAGGG-3’
     Human CD18: (Sequence published by Kishimoto et al., 1987) 
         Sense-5’- ATATAAGCTTCAGGACATGCTGGGCCTCCGCCC- 3’
         Antisense-5’- CAATTCTAGAGTGCTCCTAACTCTCAGCAAACTTGG-3’
     Human CD11a: (Sequence published by Corbi et al., 1988)
         Sense-5’- ATATAAGCTTCCTCGAGTGCTGGA-3’
         Antisense- 5’- CAATTCTAGAGCACCTCACAGGCCTGG-3’
Due to lack of a published bovine CD11a sequence, 3 sets of consensus primers 
were designed from alignment of the conserved regions of published human and 
murine CD11a sequences.
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        BovineCD11a: 
           Sense-5’- ATATAAGCTTCCTAAGCGCATGATCAGTTTCC-3’
                      5’- ATATAAGCTTGGGCCACCTGAC-3’
                      5’- ATATAAGCTTGCCCCTGGGGCCACAGG-3’
           Antisense- 5’- CAATTCTAGACTCAGTCCTTGCCAC-3’
                             5’-  CAATTCTAGACTTAGTCCTTGTCAC-3’
The following bovine CD11a primers were designed from the sequence 
published in Genbank in January 2004 (Fett et al., 2004).
           Sense - 5’- ATATAAGCTTCCCAAGAGCCCTCTGAGACT-3’
           Antisense - 5’- CAATTCTAGAGCACCTCAATCTCCACCACT-3’
All the primer sets were acquired from Integrated DNA Technologies, Inc. 
(Coralville, IA) on a fee for service basis. All the sense and antisense primers 
were diluted to a concentration of 200 µM, which was designated as ‘Stock’. For 
the actual PCR, the stock was further diluted to a working concentration of 25 
µM. 
Generation of Inserts by Polymerase Chain Reaction (PCR): Bovine CD18 
was generated using bovine cDNA in a 50 µl PCR using PCR master mix 
(Catalog # M7502, Promega, 2800 Woods Hollow Road,
Madison, WI). Briefly, the procedures recommended by the manufacturer were 
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followed, with the following cycling parameters: 1 min at 94 °C, then 35 cycles 
including: (i) 40 s at 94 °C, (ii) 30 s at 68 °C, and (iii) 2 min 30 s at 72 °C, 
followed by a final extension at 72 °C for 10 min. Human CD18 was generated 
with human cDNA and CD18 primers using similar PCR parameters as that of 
bovine CD18 except that the Tm, for human CD18 was increased to 70 °C.
Human CD11a was generated by using human cDNA with AdvantageR –GC 
cDNA PCR Kit (Catalog # K1907-1, BD Biosciences Clontech, Palo Alto, CA). 
This kit contains reagents specifically formulated to amplify cDNAs with high G:C 
content. Briefly, the procedures recommended by the manufacturer were 
followed, with the following cycling parameters: 1 min at 94 °C, then 35 cycles 
including: (i) 40 s at 94 °C, (ii) 30 s at 56 °C, and (iii) 3 min 30 s at 72 °C, 
followed by a final extension at 72 °C for 10 min. 
Bovine CD11a was generated using bovine cDNA in a long distance PCR using 
Elongase amplification technology (Invitrogen). Briefly, the procedures 
recommended by the manufacturer were followed, with the following cycling 
parameters: 2 min 30 s at 94 °C, then 35 cycles including: (i) 30 s at 94 °C, (ii) 30 
s at 56 °C, and (iii) 3 min 30 s at 68 °C, followed by a final extension at 68 °C for 
10 min. 
Selection of Cloning and Expression Vectors: pUC19 was chosen for the 
purpose of individual/separate cloning of the four desired PCR products namely 
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bovine and human CD11a and CD18. pUC19 contained a multiple cloning site 
with HindIII (AAGCTT) and XbaI (TCTAGA) restriction sites and a gene that 
conferred resistance to ampicillin. Also, pUC19 enabled the mass production of 
the inserts before their insertion into the expression vectors. pUC19 was a 
generous gift from Dr. Alain Stintzi, College of Veterinary Medicine, Oklahoma 
State University, Stillwater, OK. As per the cloning strategy, the integrin subunits 
were individually/separately cloned in pUC19 followed by transformation in E.coli
strain DH5αTM, and mass production by maxiprep (Qiagen) for their ultimate 
incorporation into the respective expression vectors.  
Two types of expression vectors were chosen, pcDNA3.1/Neo (Cat # V790-20, 
Invitrogen) and pcDNA3.1/Zeo (Cat # V860-20, Invitrogen). These vectors were 
chosen for their high-level, constitutive/co-expression in a variety of mammalian 
cell lines. Both the vectors had a cytomegalovirus (CMV) enhancer-promoter for 
high-level expression, an ampicillin resistance gene, and a pUC origin for 
selection and maintenance in E. coli strains like DH5 αTM. The only difference was 
that each vector had a different selectable marker i.e. one had neomycin 
(pcDNA3.1/Neo) and other zeocin (pcDNA3.1/Zeo). The different selectable 
markers allowed for co-selection of the recombinant expression vectors in a cell 
line. The integrin subunits cloned in pUC19 were finally incorporated in 
pcDNA3.1 expression vectors as described in the next section.
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Digestion and Ligation of Inserts with Cloning and Expression Vectors: The 
individual PCR products of bovine and human CD11a and CD18 along with 
pUC19, pcDNA3.1/Neo and pcDNA3.1/Zeo were digested with HindIII (Cat # 
R6041, Promega) and XbaI (Cat # R6181, Promega). Briefly, 1µg of the cDNA 
(bovine CD18 /human CD18 /bovine CD11a/human CD11a) was combined with
0.25 µl each of HindIII (10U/µl) and XbaI (8-12U/µl) along with 3 µl of 10X of the 
appropriate buffer in a total volume of 30 µl made up with nuclease-free water. 
This mixture was then incubated at 37 °C (water bath) for 60 min, and 
subsequently electrophoresed on a 0.6% agarose gel. The digested product(s) 
were then ligated with pUC19, pcDNA3.1/Neo and pcDNA3.1/Zeo using T4 DNA 
Ligase (Cat # M1801, Promega) and 10X ligase buffer (Cat # C1263, Promega) 
according to the manufacturer’s instructions. The following table denotes the 
placement of the coding sequence into the expression vectors.
Table 1






In order to check the authenticity of the specific ligation reactions, the ligated 
products (inserts + expression vectors) were digested with HindIII and XbaI in the 
same manner as described above.
Transformation of Recombinant Vectors/Constructs into E.coli strain DH5α: 
The ligated product(s)/construct(s) were transformed into E.coli strain DH5α
according to the manufacturer’s instructions. Briefly, 50 µl of DH5αTM cells (Cat # 
18258-012, Invitrogen life technologies, Inc., CA) were mixed with 1.0 µg of the 
respective/individual constructs and incubated on ice for 20 min. The mixture was 
further subjected to heat shock at 42 °C (water bath) for 2 min followed by 1.5 
min incubation on ice. Subsequent addition of 430 µl of pre-warmed (37 °C) LB 
broth to the mixture was followed by incubation at 37 °C (water bath) for 45 min. 
Following incubation, the mixture was plated onto LB agar containing 100 µg/ml 
ampicillin (Cat # BP1760-25, Fisher Biotech) to screen for the successful 
transformation of the ligated product(s). The plates were incubated at 37 °C 
overnight and individual colonies were picked and expanded in LB broth 
supplemented with 100 µg/ml ampicillin. The transformation was confirmed by 
harvesting the plasmid from 2 ml broth preparations (miniprep, Qiagen) and 
digesting them with HindIII and XbaI. The successfully transformed constructs 
were mass produced in LB broth and harvested using QIAGEN HiSpeed Plasmid 
Maxi Kit (Cat # 12663) for sequencing and transfection.
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Sequencing of Inserts in Recombinant Vectors/Constructs: The 5’-
CGCAAATGGGCGGTAGGCGTG-3’ Cytomegalovirus (CMV) and 5’-
TAGAAGGCACAGTCGAGG-3’  Bovine Growth Hormone (BGH) sequences 
inherently present in the expression vectors were used as forward and reverse 
primers, respectively for sequencing the respective inserts of bovine and human 
CD11a and CD18 at Recombinant DNA/Protein Resource Facility (Core Facility), 
Oklahoma State University, Stillwater and Oklahoma Medical Research 
Foundation (OMRF) on a fee-for-service basis. Sequences returned were found 
to match the bovine and human CD11a and CD18 from BLAST 
analysis/sequence alignment. 
Cultivation/Propagation of Tissue Culture Cells: The cell lines K562 (human 
erythroleukemia cell line) and HL-60 (human myeloblastic cell line) were obtained 
from and cultured as described by American Type Culture Collection, Rockville, 
MD. Briefly, the cells were propagated in RPMI-1640 medium supplemented with 
2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 20 µg of penicillin-
streptomycin/ml and 10% heat inactivated fetal bovine serum (FBS). Medium for 
HL-60 cells was supplemented with 20% FBS instead of 10%. The BL3 (bovine 
lymphoma cell line) and Vero (African green monkey kidney cell line) cells were 
obtained from the laboratories of Drs. K.D. Clinkenbeard and R. Eberle, 
respectively. BL3 cells were propagated in Minimum Essential Medium (MEM) 
supplemented with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 0.1 mM non-
essential amino acids, 1.0 mM sodium pyruvate, 10.0 µg of Gentamicin/ml and 
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10% FBS. The Vero cells were propagated in Dulbecco’s MEM supplemented 
with 2 mM L-glutamine, 10 mM HEPES, 1.5 g/L sodium bicarbonate, 1.0 mM 
sodium pyruvate, 20 µg of penicillin-streptomycin/ml and 10% FBS. The cell lines 
were cultured in 75-cm2 Corning tissue culture flasks maintained at 37 °C in a 
humidified atmosphere containing 5% CO2 .
Transfection of Recombinant Vectors/Constructs into K562, Vero and HL-
60 cells: Vero cells were plated at a density of 4-6 X 105 cells/well in a 6-well 
plate 24 hrs before transfection to provide 80-90% confluency at the time of 
transfection. Calcium phosphate transfection system (Catalog # 18306-019, 
Invitrogen Life Technologies Inc.) was used to sequentially and/or co-transfect 
Vero cells with various permutations and combinations of constructs according to 
the manufacturer’s instructions. The following tables in a 6-well plate format 
depict the type & amount (µg) of recombinant vectors (constructs), and carrier 
DNA transfected per well. 
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4-6 X 105 Vero cells/well were plated in a 6-well plate 24 hrs prior to transfection 
(Table 2):
10.0µg    pcDNA3.1/Neo    
+     Bov CD18
+ 10.0µg   Carrier DNA
10.0µg    pcDNA3.1/Neo
+     Bov CD18
+ 10.0µg   Carrier DNA
10.0µg    pcDNA3.1/Neo 
+     Bov CD18
+ 10.0µg   Carrier DNA
10.0µg    pcDNA3.1/Neo 
+     Bov CD18
+ 10.0µg   Carrier DNA






6.5µg  pcDNA3.1/Neo + 
Bov CD18
6.5µg  pcDNA3.1/Zeo +     
Hum CD11a
+ 7.0µg    Carrier DNA
6.5µg  pcDNA3.1/Neo + 
Bov CD18
6.5µg  pcDNA3.1/Zeo +     
Hum CD11a
+ 7.0µg    Carrier DNA
6.5µg  pcDNA3.1/Neo + 
Bov CD18
6.5µg  pcDNA3.1/Zeo +     
Hum CD11a
+ 7.0µg    Carrier DNA
6.5µg  pcDNA3.1/Neo + 
Bovine CD18
6.5µg  pcDNA3.1/Zeo +     
Human CD11a







Salmon sperm DNA @ 10 mg/ml was used as carrier DNA. The non-
adherent/suspension K562 cells were sequentially and/or co-transfected with 
various combinations of constructs, whereas the non-adherent HL-60 cells were 
transfected with bovine CD18 construct alone using Calcium Phosphate or 
LipofectamineTM 2000 transfection reagent (Cat # 11668-027, Invitrogen Life 
Technologies Inc.) according to the manufacturer’s instructions. Transfection of 
the K562 and HL-60 cells was similar to that described with the Vero cells. The 
tables below illustrate the transfection strategy.
6-8 X 105 K562 cells/well were plated in a 6-well plate on the day of transfection 
(Table 4):
4.0 µg  pcDNA3.1/Neo + 
Bov CD18
4.0 µg  pcDNA3.1/Zeo +     
Hum CD11a
4.0 µg  pcDNA3.1/Neo +
Bov CD18
4.0 µg  pcDNA3.1/Zeo +     
Hum CD11a
4.0 µg  pcDNA3.1/Neo +
Bov CD18
4.0 µg  pcDNA3.1/Zeo +     
Hum CD11a











6-8 X 105 HL-60 cells/well were plated in a 6-well plate on the day of 
transfection (Table 5):
4.0 µg  pcDNA3.1/Neo 
+
 Bov CD18
4.0 µg  pcDNA3.1/Neo
 +
Bov CD18
4.0 µg  pcDNA3.1/Neo 
+
Bov CD18
4.0 µg  pcDNA3.1/Neo
 +
Bov CD18





As per the published evidence of CD11a and CD18 being expressed on the cell 
surface as a heterodimer (Lally et al., 1997), the Vero and the K562 cells 
transfected with constructs containing one type of insert (bovine CD11a/human 
CD11a/bovine CD18/human CD18) were treated as controls for the cells co-
transfected with bovine and human CD11a and CD18 constructs.   
At 48 hrs post-transfection, the appropriate antibiotic (GeneticinR or ZeocinR) was 
added to the transfected cell cultures. The cells transfected with constructs 
containing the neomycin resistance cassette received GeneticinR, whereas the 
ones containing the ZeocinR resistance cassette received ZeocinR. Cells 
transfected with both pcDNA3.1/Neo and pcDNA3.1/Zeo were cultured in
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medium containing both antibiotics. The drugs were used at varying final 
concentrations of 100-500 µg/ml (GeneticinR) and 100-250 µg/ml (ZeocinR) 
depending upon the type of cell line and the recombinant vector(s) transfected. 
Cells transfected for detecting transient surface expression of integrins were not 
supplemented with antibiotics.
Immunostaining for Detection of Cell Surface Expression of Integrins by 
Confocal Microscopy: The transfectants were tested for cell surface expression 
of bovine CD18, CD11a, human CD18, CD11a by immunostaining, using 
antibodies listed in Table 6. Immunostaining was carried out by plating 1.0 X 104 
transfected Vero cells, and parent Vero cell controls in chamber slides. The 
slides were incubated at 37 °C overnight to obtain 70-80% confluency. 1.0 X 104 
K562 transfectants, and BL3 cells (positive control) were adhered to the glass 
slide by use of a cytospin instrument at 2000 rpm for 5 min. On the day of 
immunostaining, the transfected, and parent Vero, K562, and BL3 cells were 
washed 3X with warm media & immunostaining buffer (5% FBS in PBS), fixed 
with 4% paraformaldehyde for 30 min and quenched with 50 mM NH4Cl in PBS 
for 5 min at room temperature. The cells were subsequently washed three times 
with immunostaining buffer and blocked with 5% non-fat milk for 1 hr at room 
temperature. Primary antibodies such as murine anti-bovine CD18 MAb, murine 
anti-bovine CD11a/CD18 MAb, and non-specific murine (MOPC-21) MAb were 
applied at 100 µl (1:500 dilution in PBS) for 2 hrs at 4 °C.  Following three 
washes in immunostaining buffer, the cells were incubated with 100 µl (1:1000 
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dilution in PBS) of Alexa FluorR 488-labeled goat anti-mouse IgG1 secondary 
antibody (Cat # A-21121, Molecular Probes, Eugene, Oregon) for 1 hr at 4 °C. 
The cells were washed three times with immunostaining buffer, mounted with 
DAKO fluorescent mounting medium (Cat # S3023, DAKO Corporation, 
Carpinteria, CA), coversliped and analyzed with a Leica confocal microscope. 
Table 6
Anti body Specificity Clone Isotype Source
Bovine CD18 BAQ30A IgG1 VMRD, Inc., Pullman, WA
Human CD18 H20A IgG1 VMRD, Inc., Pullman, WA
Bovine CD11a/CD18 BAT75A IgG1 VMRD, Inc., Pullman, WA









Membrane Isolation from Vero Cells Transfected with Bovine CD18 
Recombinant Vector: Membrane extracts were prepared utilizing a technique 
described by Li et al. (1999) with a few modifications. Briefly, 1.0 X 109 Vero cells 
(Vero cells transfected with bovine CD18 recombinant vector and showing 
fluorescence – clones 1, 2, and 3) were washed 3 times with PBS and 
suspended in 10 ml of 50 mM 3-(N-morpholino)-propanesulphonate, pH 7.0 
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(MOPS buffer) that contained one protease inhibitor cocktail tablet (Boehringer 
Mannheim, Indianapolis, IN). The suspension was subjected to 10-passes of a 
Potter-Elvenhjem tissue grinder with a 0.1 mm clearance and subsequently 
centrifuged at 1400 g for 15 min. The pelleted, unbroken cells and nuclei were 
removed whereas the supernatant containing the membrane fraction was 
collected, centrifuged at 2500 g for 15 min and washed thrice with MOPS buffer. 
The membranes were then extracted with 1% Triton X 100 in MOPS buffer for 30 
min at 4 °C. 
Western Blotting: The membrane extracts in Triton X-100 were mixed 1:5 (v/v) 
with 6X non-reducing SDS-PAGE sample buffer and subjected to SDS-PAGE on 
8% gels (Cat # E-4325-0008, ISC Bioexpress). Following transfer to 
nitrocellulose membranes for 1h, the membranes were blocked with 3% non-fat 
dried milk (diluted in MOPS buffer), and washed three times with PBS containing 
0.05% Tween-20 (PBST). The membranes were then sequentially incubated with  
either 1:500 murine anti-bovine CD18, murine anti-bovine CD11a/CD18 or non-
specific murine (MOPC-21) MAbs for 3 hrs, and then 1:1000 biotin conjugated 
rabbit anti-mouse IgG (Cat # 315-065-003, Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA) for 1 hr and 1:2000 freshly prepared 
peroxidase conjugate (Cat # PK40000, Vectastain ABC Kit, Vector Laboratories, 
Inc., Burlingame, CA) for 30 min at room temperature. Following incubations, the 
membranes were washed thrice with PBST and the bound peroxidase was 
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developed with 3, 3’-diaminobenzidine (DAB) substrate (Catalog # SK-4100, 
Vector Laboratories Inc., Burlingame, CA).
Inhibition of Leukotoxin-induced Leukolysis/Trypan Blue Dye Exclusion 
Test: A trypan blue dye exclusion test was conducted to assess the sensitivity of 
Vero cells transfected with the bovine CD18 recombinant vector (clones 1, 2, and 
3) to LKT. Parent Vero cells and BL3 cells were used as negative and positive 
controls, respectively. In addition, some cultures were preincubated with 
antibodies against bovine CD18 to confirm that any cytolysis seen (or abrogated 
by anti-bovine CD18 antibodies) was due to specific expression of bovine CD18. 
Briefly, 2X105 BL3 cells and 80-90% confluent transfectant & Vero cells in a 96-
well plate were incubated with or without 10 µl (1:100 dilution in RPMI-1640) of 
the antibodies mentioned in Table 6 at 37 °C for 45 min. Subsequently, 0.1 µg 
(0.5 TU/ml) of LKT in 10 µl of RPMI-1640 was added to the pre-incubated cells 
followed by additional 45 min incubation at 37 °C. Exposed cells were cooled on 
ice and mixed with 100 µl 0.4% trypan blue. The viable cells were enumerated in 
triplicate using a hemocytometer, and the counts were normalized to the negative 
control: parent Vero cells, cells treated with MOPC-21 and cells with no LKT 
treatment.
Leukotoxin Activity and LDH Release Assay: LKT activity was quantified as 
toxic units (TU) by measurement of intracellular lactate dehydrogenase (LDH) 
leakage caused by incubation of 50% dilution of the LKT preparation 
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(Clinkenbeard et al., 1989b) with the transfectants (Vero cells transfected with 
bovine CD18 recombinant vector alone), parent cells (Vero, negative control) and 
BL3 cells (positive control). Briefly, 0.5 X 106 cells/well in a 96-well plate were 
incubated with 50% dilution (0.5 TU/ml) of the LKT for 2 hrs at 37 °C. The 
exposed cells were further collected by centrifugation at 700 g for 10 min and 
100 µl of supernatant from each treatment was transferred into a new 96-well flat 
bottom microtiter plate, which was then warmed to 37 °C. LDH activity was 
measured by addition of 100 µl of 37 °C assay reagent LDH-L 50 (Sigma, St. 
Louis, MO) in flat-bottomed 96-well microtiter plates. Substrate conversion was 
measured in a thermally-controlled kinetic microtiter plate reader (Thermomax, 
Molecular Devices, Palo Alto, CA) at 340 nm for 2 min at 37 °C. 
Flow Cytometric Analysis for Cell Surface Expression of Integrins: The 
transfectants (K562 cells co-transfected with bovine and human CD11a and 
CD18 recombinant vectors), parent cells (K562, negative control), and BL3 cells 
(positive control) were tested for cell surface expression of the integrins, using
murine anti-bovine CD18 MAb, anti-human CD18 MAb, anti-bovine CD11a/CD18
MAb, anti-human CD11a MAb or a non-specific murine MAb (Table 6) in a flow 
cytometric analysis according to the following procedure. Briefly, 5X105 K562 
cells, transfectants and BL3 cells were incubated with 100 µl (1:100 dilution in 
PBS) each either of BAQ30A, H20A, BAT75A, HI111, or a non-specific murine 
MAb (MOPC-21) at 4 °C for 1 hr. Following three washes in FACS buffer (3% 
fetal bovine serum in PBS), the cells were incubated with 100 µl (1:500 dilution in 
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PBS) of fluorescein isothiocyanate-labeled goat antibodies specific for mouse 
IgG (Cat # 115-095-166, Jackson ImmunoResearch Laboratories, Inc., West 
Grove, PA) at 4 °C for 1 hr. The cells were washed three times with FACS buffer, 




Identification of host cell receptor(s) of Mannheimia hemolytica leukotoxin is 
critical for understanding the pathogenesis of bovine pneumonic pasteurellosis. 
The objective of this study was to elucidate the host cell receptor (bovine CD11a 
or CD18 or the heterodimer bovine CD11a/CD18) for Mannheimia hemolytica
LKT binding and subsequent cytotoxicity. To achieve this objective, we 
transfected several LKT-resistant cell lines with different combinations of bovine 
(LKT-sensitive) and human (LKT-resistant) CD11a and CD18 recombinant 
vectors. Following transfection, the cells were screened for transient or stable 
surface expression of the ß2 integrin (CD11a/CD18) by flow cytometry, confocal 
microscopy (immuno-staining) and western blotting. LKT sensitization was 
assessed by LDH release assay and trypan blue dye exclusion following in vitro
LKT challenge. 
According to the original plan, LKT-resistant K562 cells (human chronic 
myelogenous leukemia cells) were supposed to be transfected with different 
permutations of bovine and human CD11a and CD18 constructs. The following 










Human or bovine 
CD11a or CD18 
only
Negative Resistant Heterodimer formation 




Positive Susceptible Either bovine CD11a, or 
CD18, or both necessary 
for LKT-mediated cytolysis 
Human 
CD11a/CD18
Positive Resistant Confirmation of human 








Positive Resistant LKT sensitivity restricted 
to bovine CD18
Previously, Ritchey and coworkers made several attempts to optimize the 
transfection of K562 cells with bovine CD18 recombinant vector. All such 
attempts met with failure as the transfected K562 cells did not survive for more 
than 10-14 days in the medium supplemented with GeneticinR (personal 
communication with Dr. Jerry Ritchey, August 2001). It was subsequently 
decided to use some other LKT-resistant cell line that had been widely used for 
transfections and was known to exhibit high stable recombinant protein 
expression. For that purpose, we chose Vero cells (African green monkey kidney 
cells). Another additional cell line HL-60 cells (human promyelocytic leukemia 
cells) were also transfected with different combinations of bovine and human 
CD11a and CD18 recombinant vectors. Prior to the actual transfection of 
recombinant vectors in cell lines, the following results were obtained.  
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Generation of Inserts: Bovine and human blood was collected for generating 
cDNAs for obtaining bovine and human CD11a and CD18 coding sequences. 
Briefly, the total cellular RNA was collected from in vitro concanavalin A-
stimulated bovine and human peripheral blood mononuclear cells. The RNA was 
reverse transcribed and the cDNA amplified using primers selected from the 
published sequences of bovine and human CD11a and CD18. To facilitate 
directional cloning, the sense primers were incorporated with a HindIII and the 
antisense primers with an XbaI restriction site. There were no internal HindIII or 
XbaI sites in the coding region of any of the inserts and XbaI was readily 
incorporated into the stop codon region. 
The primers amplified a single band (Figure 1) of the predicted size for bovine & 
human CD18 (~ 2400 b.p.) and human CD11a (~ 3500 b.p.). The generation of 
bovine and human CD18 and human CD11a was accomplished with only a few 
rounds of PCR optimization to acquire a clean product. However, we 
encountered an extreme difficulty in the generation of bovine CD11a coding 
sequence. First, the mRNA or cDNA sequence of bovine CD11a was not 
published at the initiation of these studies. We designed 3 sets of consensus 
primers from alignment of human and murine CD11a sequences, incorporating 
HindIII and XbaI restriction sites. Initially, an appropriately-sized PCR product 
was generated (~ 3400 b.p.). However, upon sequencing, it was determined that 
this product did not have reasonable homology with any known CD11a sequence 
from any species. Many additional attempts were made by trying different
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combinations of primers out of the 3 designed sets of consensus primers as well 
as by modifying PCR parameters (primer and cDNA concentrations, MgCl2 
concentrations, annealing temperatures). These attempts also did not result in 
generation of an appropriate- sized bovine CD11a product. 
Following multiple failures, we consulted with Dr. Udaya deSilva in the 
Department of Biochemistry and Molecular Biology, Oklahoma State University 
for trouble-shooting suggestions. Considerations were: first, at 3400 b.p., the 
amplification may have been precluded by inadequate length of the cDNA from 
inefficiency at the RT step. Secondly, the amplification may have been hampered 
by the presence of secondary structures or GC rich regions in the bovine cDNA. 
To compensate for these possible problems, we changed the parameters for RT-
PCR (using a third-generation RT enzyme) and also included the use of an 
Advantage-GC cDNA PCR kit during amplification to more efficiently melt the 
G:C rich regions in the cDNA. These efforts were also unsuccessful. In January 
2004, new sense and antisense primers were designed from recently published 
sequence of bovine CD11a (Fett et al., 2004). Using these primers and 
modifications of the RT and PCR parameters, an appropriate-sized (~ 3500 b.p.) 
product was generated as shown in Figure 1.
Cloning and Ligation of Inserts in pUC19 and Expression Vectors: All four 
inserts were first cloned into pUC19 (small, high copy number, E.coli plasmids, 
2686 b.p. in length) followed by subcloning into expression vectors –
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pcDNA3.1/Neo and pcDNA3.1/Zeo. pUC19 contained a multiple cloning site with 
HindIII (AAGCTT) and XbaI (TCTAGA) restriction sites and a gene that conferred 
resistance to ampicillin. Further, it produces an α-peptide of ß-galactosidase, 
which complements the lac deletion mutation in E.coli strains such as DH5αTM. 
This implies that when such strains (like DH5αTM) are transformed by non-
recombinant vectors (i.e. pUC19 alone), blue colonies are generated on plates 
containing X-gal, whereas white or colorless colonies are formed on the same 
plates by vectors with inserts. The inserts and pUC19 were individually digested 
with HindIII and XbaI and further ligated with T4 DNA Ligase as described in the 
materials and methods section. Figure 2 shows the results of HindIII and XbaI
digestion of pUC19 containing an insert.
Expression vectors pcDNA3.1/Neo (5428 b.p.) and pcDNA3.1/Zeo (5015 b.p.) 
were selected for their high-level, stable and non-replicative transient expression 
in a variety of mammalian cell lines. Both the vectors had cytomegalovirus (CMV) 
enhancer-promoter sequences for high-level constitutive expression, a large 
multiple cloning site in forward (+) and reverse (-) orientations to facilitate 
directional cloning, the bovine growth hormone (BGH) polyadenylation signal and 
transcription termination sequences for enhanced mRNA stability, an ampicillin 
resistance gene, and pUC origin for selection and maintenance in E. coli strains 
like DH5αTM. The only difference between the two vectors was the resistance 
cassette, NeomycinR vs ZeocinR. Bovine and human CD11a were individually 
ligated into pcDNA3.1/Zeo, whereas bovine and human CD18 were ligated into
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pcDNA3.1/Neo. Figure 3 shows the results of digestion of ligated expression 
vectors and inserts with HindIII and XbaI.
Sequencing of Inserts: The bovine and human CD11a and CD18 inserts were 
sequenced in pcDNA3.1 using CMV forward and BGH reverse primers. The 
sequencing results were successfully matched with the respective published 
sequence data available from National Center for Biotechnology Information 
(NCBI).
Cultivation/Propagation of Cell Lines: Figure 4 illustrates the morphology of 
the cell lines at 20X. K562 and Vero cell lines were chosen for LKT resistance 
secondary to the lack of CD11/CD18 surface expression. Though HL-60 cells 
naturally express human CD11a/CD18 on their surface, these cells were chosen 
to be transfected with bovine CD18 recombinant vector alone in an attempt to 
produce a chimeric heterodimeric surface expression of a chimeric human 
CD11a/bovine CD18 heterodimer. In the majority of experiments conducted 
during this study, BL3 cells were used as positive control as they exhibited a 
natural surface expression of bovine LFA-1 or CD11a/CD18 and were sensitive 
to LKT. In some experiments, bovine PBMCs were used as positive control. All 
the above-mentioned cell lines were non-adherent or suspension cells except the 
Vero cells, which adhered to the surface of the cultivation/propagation flask or 
plate. 
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Strategy and Transfection of Recombinant Vectors into Cell Lines: After the 
initial failure of K562 cells transfected with bovine CD18 subunit to survive in the 
GeneticinR supplemented medium, Vero cells were chosen for transfection with 
different combinations of recombinant vectors because these cells are leukotoxin 
resistant and exhibit a well-known ability and stability for expressing recombinant 
proteins. Vero cells were transfected with bovine and human CD18 recombinant 
vectors using calcium phosphate and were selected with GeneticinR for further 
testing of stable CD18 expression. Although, a single subunit (either CD11or 
CD18) is not expected to have surface expression by itself (Marlin et al., 1986), 
the selected Vero cell clones were tested for surface expression of bovine CD18 
by immunostaining and western blotting. The Clones were also checked for LKT 
sensitivity by trypan blue exclusion and LDH release assay. 
Due to the low unexpected expression of a single subunit (bovine CD18) 
exhibited by Vero cells, all further transfection studies were discontinued in these 
cells. K562 cells were again pulled out of the freezer and chosen for transfection 
on account of their ability to be efficiently tested by flow cytometry and previously 
demonstrated stable recombinant human CD11a/CD18 expression (Lally et al., 
1997). These cells were transfected with bovine CD18 alone as well as different 
combinations of bovine and human CD11a and CD18 recombinant vectors using 
the same calcium phosphate transfection system. 48 hrs following transfection, 
one-half of the transfected cells were subjected to flow cytometric analysis and 
immunostaining to detect the transient surface expression of the above-
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mentioned inserts, while the other half of the transfected cells were 
supplemented with selection antibiotics for 2-3 weeks post-transfection to select 
clones that might exhibit stable cell surface expression of the heterodimeric 
integrin.
HL-60 cells, which naturally express human CD11a/CD18, were transfected with 
bovine CD18 recombinant vector alone followed by 48 hrs post-transfection 
selection with geneticin (500 µg/ml) to detect stable surface expression of 
chimeric human CD11a/bovine CD18 heterodimer.
Immunostaining and Confocal Microscopy Results of Transfected Vero 
Cells along with Positive and Negative Control: Figure 5 (A), (B), and (C) 
depict the confocal, transmitted, and the overlay images of the fluorescent bovine 
PBMCs (positive control) indicating cell surface expression of CD11a/CD18 when 
stained with bovine anti CD11a/CD18 MAb (BAT75A). The confocal, and 
transmitted images of the wild type K562 (D, and E) & Vero cells (F, and G) 
stained with the same BAT75A MAb exhibited a lack of CD11a/CD18 surface 
expression as expected.
Briefly, following transfection with bovine CD18 recombinant vector alone, fifteen 
clones continued to grow in the selective (GeneticinR) media. Three out of fifteen 
clones indicated low level of cell surface expression of bovine CD18 based upon 
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fluorescent immunostaining. Results of experiment with one representative clone 
out of three are shown in Figure 6.
The three Vero cell clones identified with weak fluorescence were grown on 
chamber slides and transfected with human CD11a recombinant vector in an 
attempt to enhance the low expression of bovine CD18 by eventual expression of 
a chimeric heterodimer human CD11a/bovine CD18. 48 hrs post-transfection, 
one half of the transfected Vero cell clones were tested for transient human 
CD11a/bovine CD18 expression, while the other half was supplemented with 
GeneticinR and ZeocinR inorder to obtain clones that stably express the chimeric 
heterodimer. 
Figure 7 (A), (B), and (C) exhibit the fluorescent confocal, transmitted, and 
overlay images of one of the Vero cell clones rescued with human CD11a when 
detected with BAQ30A MAb and fluorescent secondary antibody reagent. There 
was low transient surface expression of the supposed chimeric heterodimer 
human CD11a/bovineCD18 that could not be interpreted different from the level 
of expression of the clones transfected with bovine CD18 alone. Panels (D), and 
(E) along with (F), and (G) represent the confocal, and transmitted images of wild 
type Vero cells transfected with human CD11a, and bovine CD18 when detected 
with H1III, and BAQ30A MAbs, respectively. The Vero cells transfected with 
human CD11a, and bovine CD18 recombinant vectors alone as controls did not 
fluoresce. The Vero clones selected for stable expression of chimeric human 
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CD11a/bovine CD18 following rescue with human CD11a subunit did not survive 
long enough in the selective media to be tested. 
Western Blotting Results: The membrane extracts from the Vero cell clones 
expressing low levels of bovine CD18 were subjected to SDS-PAGE on 8% gels. 
Two out of the three clones in Figure 8 (A), lanes 1, and 3 exhibit a band 
between 78 and 132 kDa and within the range of 95-100 kDa bovine CD18 when 
incubated with BAQ30A as the primary antibody. No band was detected on blots 
incubated with an irrelevant antibody (MOPC-21) or PBS alone (negative 
controls). A band at 78 kDa was present in all the blots, including the negative 
controls, indicating non-specific binding of the secondary antibody or peroxidase 
conjugate to a protein in this region. All subsequent attempts to detect the bovine 
CD18 expression (band) using membrane extracts prepared from subsequent 
Vero cell clones met with failure.   
Assessment of LKT Sensitivity: Sensitivity of CD18-expressing Vero clones to 
M. hemolytica LKT was tested by in vitro LKT challenge and the subsequent 
cytotoxicity was measured by 
a) Trypan blue dye exclusion, and 
b) LDH release assay
63
To confirm that the cytotoxic effect was mediated by bovine CD18, some cultures 
were pretreated with anti CD18 MAb to interfere with the receptor:leukotoxin 
binding, and thus protect LKT-sensitive cells from LKT challenge.
Trypan Blue Dye Exclusion Test:  Trypan blue dye exclusion was conducted to 
test the apparent bovine CD18-expressing Vero clones for LKT sensitivity. 
Attempts to assess the inhibitory effect of BAQ30A, and MOPC21 MAbs on 
transfectants (Vero cells transfected with bovine CD18 recombinant vector alone 
- clones 1, 2 and 3), parent cells (Vero, negative control) and BL3 cells (positive 
control) pre-incubated with M. hemolytica LKT were performed. The pre-
incubation of BL3 cells with BAQ30A caused inhibition of LKT-induced cytolysis, 
but the non-specific murine MAb (MOPC21) did not inhibit LKT-induced cytolysis 
(Table 8). None of the Vero cell clones 1, 2 or 3 that exhibited fluorescence 
through bovine CD18 immunostaining showed any cytolysis when incubated with 
LKT. The counts were normalized to the parent Vero cells, non-specific murine 
MAb (MOPC21) and no LKT + no MAb.
LDH Release Assay: The LDH release assay was used to monitor the LKT-
induced target cell lysis. LKT activity was quantified as toxic units (TU) by 
measurement of intracellular lactate dehydrogenase (LDH) leakage caused by 
50% dilution of the LKT preparation. TU was determined by graphing specific 
LDH leakage versus the culture supernatant dilution factor. One TU was defined 
as the dilution factor at which the specific LDH leakage was 50% for 4 × 106 BL3 
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cells ml−1 exposed for 2 hrs at 37 °C. BL3 cells (positive control) showed LDH 
release (~450 U/ml) compared to the negative control (parent Vero cells) (Figure 
9). Similar to the findings with trypan blue dye exclusion, the LDH release from 
the Vero cell clones was similar to that seen with the wild-type Vero cells (Figure 
9).  
Flow Cytometric Analysis of Transfected K562 Cells: On account of 
equivocal expression of bovine CD18 on Vero cell clones detected by a number 
of techniques, limited ability of Vero cells to be tested by flow cytometric analysis, 
and/or inherent sturdiness of Vero cells to incubation with LKT, further 
transfection or testing of Vero cell clones was discontinued. K562 cells being 
non-adherent and previously tested by Lally et al. (1997) for recombinant human 
CD11a/CD18 expression were chosen for transfection with different 
combinations of recombinant vectors. Also, by this time, we had generated the 
bovine CD11a recombinant vector. As per the earlier mentioned strategy, K562 
cells were transfected with different combinations of bovine and human CD11a 
and CD18.
ß2 integrins are expressed as heterodimers of α and ß subunits (Gahmberg et al., 
1998). It has been documented that the α subunit (CD11) and the ß subunit 
(CD18) have to associate with each other to be transported to the plasma 
membrane and expressed on the cell membrane (Marlin et al., 1986). Therefore, 
it was of interest to determine whether bovine CD18 was expressed as a 
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heterodimer with bovine and/or human CD11a as well as human CD18 with 
bovine and/or human CD11a in co-transfected K562 cells. To confirm 
heterodimeric expression, or to disprove the notion of CD18 expression alone as 
a single subunit as seen in Vero cell clones, K562 cells were initially transfected 
with bovine CD18 recombinant vector alone and selected in GeneticinR-
supplemented medium to generate clones that stably expressed bovine CD18. 
The clones obtained by culture in selective media tested negative for cell surface 
expression of bovine CD18 using flow cytometric analysis.
Figure 10 shows the results of flow cytometric analysis used to detect the 
transient cell surface expression of bovine and human CD18 heterodimerized 
with their α subunit counterparts bovine and human CD11a, respectively, in K562 
cells transfected with bovine CD11a and CD18, and human CD11a and CD18 
recombinant vectors. The results indicated low level of expression for bovine 
CD11a/CD18, and human CD11a/CD18. According to the findings of Martin et al.
(1986) and our expectation, none of the control cells transfected singly with 
bovine or human CD11a or CD18 alone showed any level of surface expression 
of α (CD11a) or β (CD18) subunit. The co-transfected K562 cells selected with 
GeneticinR and ZeocinR for stable cell surface expression of bovine and human 
β2 integrins could not be tested as they did not survive and perished within 10-14 
days post-transfection. The generation of stable expressing clones was 
attempted multiple times, but every time, the transfected cells did not survive 
long enough in the selective media to be subsequently tested.
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Immunostaining and Confocal Microscopy Results of Transfected K562 
Cells: K562 clones transfected with bovine CD18 alone and isolated from the 
selective medium were co-transfected with bovine and/or human CD11a in an 
attempt to induce surface expression of the heterodimer. 48hrs following 
transfection, one half of the transfected K562 cell clones rescued with bovine or 
human CD11a were tested for transient heterodimer expression, while the other 
half was supplemented with selection antibiotics, GeneticinR and ZeocinR inorder 
to obtain clones with stable expression.
 Figure 11 (A), (B), and (C) exhibit the fluorescent confocal, transmitted, and the 
overlay images of bovine CD18-K562 cell clones rescued with bovine CD11a 
when detected with BAT75A MAb. While (D), (E), and (F) depict the fluorescent 
confocal, transmitted, and the overlay images of fluorescent K562 cell clones 
rescued with human CD11a when detected with BAQ30A MAb. Based on the 
fluorescent intensity, there was weak cell surface expression of both bovine 
CD11a/CD18 and chimeric human CD11a/bovine CD18. The K562 cells selected 
with GeneticinR and ZeocinR for the stable expression of the above-mentioned 
heterodimers did not survive long enough to be tested after multiple attempts.
Figure 12 (A), (B), and (C) exhibit the fluorescing confocal, transmitted, and 
overlay images of K562 cells co-transfected with bovine CD11a and CD18 when 
detected with BAQ30A MAb 48 hrs post-transfection. The fluorescence intensity 
of the images indicated some level of transient surface expression of bovine 
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CD11a/CD18. Panels (D), and (E) along with (F), and (G) represent the confocal, 
and transmitted images of wild type K562 cells transfected with bovine CD11a 
alone, or bovine CD18 alone when detected with H1III, and BAQ30A MAbs, 
respectively. As expected, the control K562 cells transfected with bovine CD11a 
or bovine CD18 recombinant vectors alone did not fluoresce. The co-transfected 
K562 cells selected for stable expression of bovine CD11a/CD18 did not survive 
long enough in the selective media to be tested. 
Figure 13 (A), (B), and (C) exhibit the fluorescent confocal, transmitted, and 
overlay images of fluorescent K562 cells co-transfected with human CD11a and 
CD18 when detected with H20A MAb 48 hrs post-transfection. The fluorescence 
intensity of the images indicated some level of transient surface expression of 
human CD11a/CD18. Panels (D), and (E) along with (F), and (G) represent the 
confocal, and transmitted images of K562 cells transfected with either human 
CD11a or CD18 alone when detected with H1III, and H20A MAbs, respectively. 
The control K562 cells transfected with human CD11a or human CD18 
recombinant vectors alone did not fluoresce as expected. Similar to the other 
attempts, the co-transfected K562 cells selected for stable expression of human 
CD11a/CD18 did not survive long enough in the selective media to be tested 
after multiple attempts. 
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(A)                                          (B)  
(C)   (D)                                                                 
Figure 1. 0.6% agarose gels stained with ethidium bromide with 
amplification products for bovine CD18 (panel A), human CD18 (panel B), 
bovine CD11a (panel C), and human CD11a (panel D). All products were of 
expected size: CD18 (~ 2400 b.p.), CD11a (~ 3500 b.p.). Lane 1 in all the panels 








(A)                                                (B)
(C)                                               (D)   
Figure 2. Cloning of inserts into pUC19 cloning vector. All panels are 0.6% 
agarose gels stained with ethidium bromide. Lane 1 & 2 in all the panels is 1.0 kb 
ladder and linearized pUC19 with HindIII and XbaI, respectively. Panel A, lane 3 
is digested pUC19 and bovine CD18; Panel B, lane 3 is digested pUC19 and 
human CD18; Panel C, lane 3 is digested pUC19 and bovine CD11a; Panel D, 













(A)             (B)
 (C)                                            (D)
Figure 3. Subcloning of inserts into pcDNA3.1 expression vectors. All panels 
are 0.6% agarose gels stained with ethidium bromide  Panel A, lane 4 is digested 
pcDNA3.1/Neo and bovine CD18; Panel B, lane 4 is digested pcDNA3.1/Neo 
and human CD18; lane 1, 2 & 3 in panel A & B are 1.0 kb ladder, linearized 
pcDNA3.1/Neo with HindIII & XbaI and linearized pcDNA3.1/Neo + bovine or 
human CD18, respectively. Panel C, lane 4 is digested pcDNA3.1/Zeo and 
bovine CD11a; Panel D, lane 4 is digested pcDNA3.1/Zeo and human CD11a; 
lane 1, 2 & 3 in panel C & D are 1.0 kb ladder, linearized pcDNA3.1/Zeo with 

























(A)                                                       (B)
(C)                                             (D)
Figure 4. Morphology of the cell lines used in this study. (A) Vero cells, 
adherent, fibroblast-like; (B) K562 cells, suspension, lymphoblast; (C) HL-60 
cells, suspension, myeloblastic; (D) BL3 cells, suspension, lymphoblast. All the 
cell lines have been photographed at 20X.
72
(A)        (B)           (C)           
(D)                     (E)        
(F)                    (G)
Figure 5. Confocal microscopy images of positive and negative control cells 
exhibiting surface expression of β2 integrins. (A), (B), and (C) Confocal, 
transmitted, and overlay images of bovine PBMCs (positive control) exhibiting 
CD11a/CD18 surface expression. (D), and (E) Confocal, and transmitted images 
of wild type K562 cells exhibiting no CD11a/CD18 expression. (F), and (G) 
Confocal, and transmitted images of wild type Vero cells exhibiting no 
CD11a/CD18 expression. Anti CD11a/CD18 MAb (BAT75A) was used to detect 
the cell surface expression.
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(A)                                           (B)
(C)
Figure 6. Confocal microscopy images of Vero cells exhibiting surface 
expression of bovine CD18. Vero cells were transfected with bovine CD18 
recombinant vector alone and selected for stable expression with geneticin: (A)
Stable cell surface expression of bovine CD18 detected with BAQ30A MAb. (B)
No surface expression of bovine CD18 detected with non-specific mouse IgG 
(MOPC21). (C) Wild type Vero Cells showing no bovine CD18 expression as 
detected with BAQ30A MAb. Results of experiment with one representative clone 
out of three are shown. 
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(A)         (B)                (C)       
(D)                (E)        
(F)                      (G)
Figure 7. Confocal microscopy images of Vero cells exhibiting surface 
expression of chimeric human CD11a/bovine CD18. Vero cells clones 
expressing bovine CD18 were transfected with human CD11a recombinant 
vector to augment the surface expression of bovine 18. (A), (B), and (C)
Confocal, transmitted, and overlay images of surface expression of bovine CD18 
detected with BAQ30A MAb. (D), and (E) No surface expression of human 
CD11a on Vero cells transfected with human CD11a alone and detected with 
H1III MAb. (F), and (G) No surface expression of bovine CD18 on Vero cells 
transfected with bovine CD18 alone and detected with BAQ30A MAb.
75
(A)                                                           (B)
(C)                                                (D)
Figure 8. Western blots showing the surface expression of bovine CD18 on 
transfected Vero cells. The transfectants (Vero cells transfected with bovine 
CD18 alone, i.e., clones 1, 2 & 3) membrane extracts in Triton X 100 were mixed 
1:5 (v/v) with 6X non-reducing SDS-PAGE sample buffer and subjected to SDS-
PAGE on 8% gels. Following transfer to nitrocellulose membranes, the 
membranes were blocked with 3% non-fat dried milk, and sequentially incubated 
with 1:500 BAQ30A (Panel A), BAT75A (Panel B), MOPC-21 (Panel C) MAbs, 
and PBS (Panel D) for 3h, 1:1000 biotin conjugated rabbit anti-mouse IgG for 1h 
and 1:2000 freshly prepared peroxidase conjugate for 30 minutes at room 
temperature. Following incubations, the bound peroxidase was developed with 3, 
3’-diaminobenzidine (DAB) substrate. Lanes 1, 2 and 3 in all the panels are 
membrane extracts of clones 1, 2 & 3, respectively. Lane 4 is the broad range 













Table 8. Inhibition of LKT-mediated cytolysis by anti-bovine CD18 MAb 
(BAQ30A) or murine irrelevant MAb. BL3 cells (positive control), Vero cells 
(negative control) and Clones 1, 2 & 3 (Vero cells transfected with bovine CD18 
recombinant vector alone) were incubated with 10 µg of the above mentioned 
MAb in 90 µl RPMI-1640 for 45 min at 37°C, prior to addition  of 10 µl RPMI-1640 
containing 0.1 µg LKT and an additional 45 min incubation. The exposed cells 
were mixed with trypan blue and number of viable cells enumerated by manual 
counting. 










No LKT + No MAb 86 ±11 90  ±  4 86  ±  4 85  ±  2 93  ±  2
LKT + No MAb 7 ± 2 87  ±  8 88  ±  6 89  ±  5 90  ±  1
LKT + anti-bovineCD18 MAb (BAQ30A) 44 ±13 94  ±  3 92  ±  2 81  ±  6 87  ±  5





















Figure 9. Leukotoxin-mediated lysis of BL3 cells (positive control), Vero cells 
(negative control) and Clones 1, 2, 3 & 4 (Vero cells transfected with bovine 
CD18 only) at 50% LKT dilution. The assay was done in triplicate and the error 
bars indicate standard deviations of the means.
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(A)                                             (B)
 (C)
(D)                                          (E)
(F)                                          (G)
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(H)                (I)                                
(J)                      (K)
Figure 10. Flow histograms showing the cell surface expression of bovine 
and human β2 integrins in transfected K562 cells 48 hrs post-transfection.
(A), and (B) PBMCs (positive control) expressing bovine CD11a/CD18 as 
detected by BAT75A, and BAQ30A MAbs, respectively. (C) Wild type K562 
negatively expressing CD11a/CD18 as detected by BAT75A MAb. (D), and (E)
K562 cells transfected with bovine CD11a and CD18 expressing bovine 
CD11a/CD18 as detected by BAT75A, and BAQ30A MAbs, respectively. (F)
K562 cells transfected with bovine CD11a alone depicting no expression as 
detected by H1III MAb. (G) K562 cells transfected with bovine CD18 alone 
depicting no expression as detected by BAQ30A MAb. (H), and (I) K562 cells 
transfected with human CD11a and CD18 expressing human CD11a/CD18 as 
detected by H20A, and H1III MAbs, respectively. (J) K562 cells transfected with 
human CD11a alone depicting no expression as detected by H1III MAb. (K)
K562 cells transfected with human CD18 alone depicting no expression as 
detected by H20A MAb.
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(A)                  (B)      (C)
(D)               (E)              (F)
Figure 11. Confocal microscopy images of K562 cells exhibiting rescued 
surface expression of bovine and human CD11a/bovine CD18 48 hrs 
posttransfection. K562 cells clones living in the selective medium but not 
expressing bovine CD18 were transfected with bovine as well as human CD11a 
recombinant vector to rescue the surface expression of bovine CD18. (A), (B), 
and (C) Confocal, transmitted, and overlay images of surface expression of 
bovine CD18 rescued by bovine CD11a as detected with BAT75A MAb. (D), (E), 
and (F) Confocal, transmitted, and overlay images of surface expression of 
bovine CD18 rescued by human CD11a as detected with BAQ30A MAb.
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(A)        (B)              (C)              
(D)                 (E)        
 (F)                   (G)
Figure 12. Confocal microscopy images of K562 cells exhibiting co-
expression of bovine CD11a/CD18. K562 cells were co-transfected with bovine 
CD11a and CD18 recombinant vectors to detect the transient surface expression 
of bovine CD11a/CD18 48 hrs posttransfcetion. (A), (B), and (C) Confocal, 
transmitted, and overlay images of surface expression of bovine CD11a/CD18 
detected with BAT75A MAb. (D), and (E) Confocal, and transmitted images of 
negative surface expression of bovine CD11a on K562 cells transfected with 
bovine CD11a alone and detected with H1III MAb. (F), and (G) Confocal, and 
transmitted images of negative surface expression of bovine CD18 on K562 cells 
transfected with bovine CD18 alone and detected with BAQ30A MAb.
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 (A)                         (B)       (C)
(D)                 (E)                      
(F)                  (G)
Figure 13. Confocal microscopy images of K562 cells exhibiting co-
expression of human CD11a/CD18. K562 cells were co-transfected with human 
CD11a and CD18 recombinant vectors to detect the transient surface expression 
of human CD11a/CD18 48 hrs posttransfcetion. (A), (B), and (C) Confocal, 
transmitted, and overlay images of surface expression of human CD11a/CD18 
detected with H20A MAb. (D), and (E) Confocal, and transmitted images of 
negative surface expression of human CD11a on K562 cells transfected with 
human CD11a alone and detected with H1III MAb. (F), and (G) Confocal, and 
transmitted images of negative surface expression of human CD18 on K562 cells 
transfected with human CD18 alone and detected with H20A MAb.
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Chapter 4
General Discussion and Conclusions
Mannheimia hemolytica is the etiological agent for an economically important 
pneumonic disease of cattle that causes almost a billion dollars in annual losses 
to the beef cattle industry in North America (Whiteley et al., 1992). A critically 
important virulence factor for this organism is leukotoxin, an exotoxin elaborated 
by M. hemolytica that destroys bovine immune cells sent to protect the host. Data 
generated by several investigators strongly suggests an important role of ß2 
integrins as receptor for binding and subsequent toxicity secondary to M. 
hemolytica LKT (Ambagala et al., 1999; Jeyaseelan et al., 2000; Li et al., 1999; 
Wang et al., 1998). Based on their observation that MAbs specific for 
CD11a/CD18 and CD18 inhibited LKT-mediated apoptosis, Wang et al. (1998) 
were the first to report identification of ß2 integrins as a receptor for the LKT. 
Identification of a 95-100 kDa protein by a MAb specific for bovine CD18 in the 
eluant from LKT-labelled beads, preincubated with lysate from BL3 (bovine 
lymphoma 3) cells, prompted these workers to suggest that bovine CD18 is 
involved in LKT binding to bovine leukocytes. Binding of bovine CD18 isolated
from BL3 cells by LKT in ligand blotting experiments, and partial inhibition of 
LKT-induced cytolysis by anti-CD18 (BAQ30A) or anti-CD11a/CD18 (BAT75A) 
MAbs, prompted Li et al. (1999) to propose bovine CD18 as a species-specific 
receptor for M. hemolytica LKT. 
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In other studies (Ambagala et al., 1999), four proteins were isolated from 
polymorphonuclear (PMN) cell lysates run over LKT-affinity columns. The 
proteins had relative molecular masses of 180, 170, 150, and 95 kDa. The amino 
acid sequence data clearly identified the 170-kDa band as CD11b. Furthermore, 
the PMN proteins eluted from the LKT-bound column reacted with MAbs specific 
for CD11a, CD11b, CD11c, and CD18 in a radioimmunoassay indicating that the 
proteins contained all the three α subunits (CD11a, CD11b, and CD11c) and the 
ß subunit (CD18) of ß2 integrins. These results suggested that the CD18 subunit 
brought down all the three α subunits along with it when the cell lysate was 
passed through a column prebound with LKT. In addition, in a cytotoxicity 
inhibition assay, an anti-CD18 MAb reduced LKT-induced cytotoxicity of bovine 
PMNs by more than 50%. Taken together, these results indicated that M. 
hemolytica LKT binds to ß2 integrins, most likely via CD18 (Ambagala et al., 
1999; Li et al., 1999). However, a later study by Jeyaseelan et al. (2000), based 
on western blot analysis of proteins eluted from LKT-labelled beads and blocking 
experiments with integrin subunit-specific MAbs, concluded that LKT binds to 
CD11a and not to CD18.
This study was designed to resolve the discrepancy on the role of bovine CD18 
in leukotoxin-induced cytolysis as reported in the literature. It was reasoned that 
the recombinant expression of an immunobiologically-active bovine CD18 with 
human or bovine CD11a on LKT-resistant cells and examination of the
susceptibility to LKT-induced cytolysis would unequivocally determine the role of
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bovine CD18 in M. hemolytica LKT-induced cytotoxicity. Examination of LKT-
induced lysis of cells rather than binding of LKT to the cells was chosen for 
analysis since binding of LKT to bovine leukocytes is not specific. It has been 
demonstrated that leukotoxin also binds to some non-ruminant leukocytes 
without eliciting any effects (Jeyaseelan et al., 2000).  
Toward the goal of characterizing the interaction between LKT and the putative 
host cell receptor CD18, the strategy was to establish stable transfected cell lines 
expressing bovine CD11a/CD18, human CD11a/CD18, or hybrid ß2 integrins
such as human CD11a/bovine CD18, bovine CD11a/human CD18 and to 
characterize their sensitivity to LKT. Coding sequences for bovine CD18, and 
human CD11a and CD18 were readily generated utilizing primers generated from 
published sequences. Sequence information for bovine CD11a initially was not 
available and obtaining the full length coding sequence was difficult and time-
consuming. Although the bovine CD11a coding sequence was eventually 
generated, the probable pitfall apart from the ones mentioned in the results 
section in generating the bovine CD11a subunit might have been selection of 
incorrect primer combinations from the consensus sequences. Although 
consensus sequences are largely utilized for designing primers using the regions 
that are conserved across different species, it is not always certain that the 
designed consensus primers would yield the desired result. Atleast in this case, 
even three sets of consensus primers did not generate a full length bovine 
CD11a sequence that had reasonable homology with CD11a sequences from 
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other species. Furthermore, when alignment of the consensus primers with the 
full length coding sequence of bovine CD11a published by Fett et al. (2004) was 
attempted, none of the consensus primer sets aligned. This clearly implied that 
none of the consensus primer sets hybridized with bovine cDNA in the first place. 
Ultimately, the bovine CD11a coding sequence published by Fett et al. (2004) 
was used to design the primers with incorporation of HindIII & XbaI in the sense 
and antisense primers, respectively. This primer set finally yielded a product 
(~3500 b.p.) that matched the full length bovine CD11a coding sequence. 
 While working to acquire bovine CD11a coding sequence, the three coding 
sequences already in hand (bovine CD18, and human CD11a and CD18) were 
cloned in pUC19 and ligated into a pcDNA3.1 expression vector with either a 
NeomycinR or ZeocinR resistance cassette. According to the original plan, LKT-
resistant K562 cells were selected to be transfected with different combinations 
of recombinant vectors on account of the relative ease of testing these cells with 
flow cytometric analysis and previous documentation of recombinant human 
CD11a/CD18 surface expression by Lally et al. (1997). However, multiple 
attempts to optimize transfection conditions in K562 cells with bovine CD18 
recombinant vector alone failed. Therefore, Vero cells were chosen for 
expression on account of their known high stable recombinant protein expression 
characteristics. Thus, Vero cells were transfected with bovine and human CD18 
recombinant vectors. Three Vero cell clones transfected with bovine CD18 
survived in the selective (GeneticinR) media and exhibited low levels of bovine 
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CD18 expression as determined by immunostaining and fluorescent confocal 
microscopy. None of the human CD18 clones isolated from the selective media
exhibited any surface expression of CD18. As a matter of fact, any CD18 
expression at this juncture was unexpected as CD18 is reportedly only 
expressed as a heterodimer with CD11 (Marlin et al., 1986), which was not co-
transfected in this experiment. Therefore, the low levels of bovine CD18 
expression as determined by immunostaining and fluorescent confocal 
microscopy was surprising.
The expression of bovine CD18 by Vero cells when transfected alone was 
paradoxical. Did bovine CD18 rescue a CD11 subunit? Did bovine CD18 
heterodimerize with some other subunit in the endoplasmic reticulum of Vero 
cells, got transported and expressed on the cell surface? To answer these 
questions, we extracted the cell membranes from the three bovine CD18-
expressing clones and tested the membrane extracts with anti-bovine CD18 
(BAQ30A), anti-bovine CD11a/CD18 (BAT75A), and murine non-specific 
(MOPC-21) MAbs for the expression of bovine CD18 via western blotting. Two 
out of the three clones exhibited a band in the range of bovine CD18 (95-100 
kDa) when detected with anti-bovine CD18 MAb (BAQ30A). Anti-CD11a/CD18 
MAb (BAT75A) did not label the CD18-expressing clones. However, this might 
have been due to lack of specificity or CD11a expression. All subsequent 
attempts to reproduce the bovine CD18 product from these three Vero cell clones 
following passage were failures. 
88
Although the bovine CD18 expression was certainly low, we tested the Vero cell 
clones for LKT-sensitivity with a trypan blue dye exclusion test and LDH release 
assay. Trypan blue dye exclusion test was conducted to assess lysis of the Vero 
cell clones when challenged with the LKT. To prove that the lysis was mediated 
through engagement of CD18, the cells were protected before LKT challenge 
with anti-bovine CD18 antibodies. None of the clones exhibited cell death that 
was significantly different from the parent Vero cells when incubated with the LKT 
alone. The anti-bovine CD18 MAb inhibited around 45-50% cytolysis of  BL3 cells, 
whereas the cell viability among clones and parent Vero cells was no different 
from cells incubated with LKT alone. 
LDH release assay is regarded as the ‘gold standard’ for testing the biological 
activity of bovine CD18 expressed by the Vero cells because it has been used for 
this purpose by other investigators (Sun et al., 2000; Murakami et al., 2002). 
Also, the LDH release assay is more sensitive to cell injury that does not result in 
cell death. This assay was utilized to elucidate the impact of LKT-induced 
cytolysis on CD18 expressing cells following incubation with 0.5 U/ml of the LKT 
preparation by measurement of intracellular lactate dehydrogenase (LDH) 
leakage. The amount of LDH leakage was directly proportional to concentration 
of LKT used and the expression of bovine CD18 on target cells. Sun et al. (2000) 
showed the lytic effects of 0.1 and 1.0 U/ml of a LKT preparation on bovine 
lymphocytes. We chose 0.5 U/ml concentration of the LKT to enable the LKT to 
bind and lyse the bovine CD18 expressing Vero cell clones. Except for the 
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positive control BL3 cells, none of the clones and/or the parent Vero cells 
exhibited LDH leakage due to LKT treatment . 
The results of the trypan blue dye exclusion test and LDH release assay 
suggested several possibilities. First, the equivocal CD18 expression raised the 
possibility of LKT not binding to the cloned CD18 molecule or that CD18 
expression with CD11 as a heterodimer is critical for LKT: receptor interaction 
that results in cell death. Furthermore, we could not rule out factors independent 
of CD18 expression in the resistance of Vero cells to the LKT. One such factor 
could be the sturdiness of these cells that makes them inherently resistant to the 
LKT even though they are forced to express the CD18 molecule. At the end of 
studies conducted with the Vero cells, there were still many unanswered 
questions such as why was bovine CD18 apparently expressed alone? Did the 
bovine CD18 subunit rescue a monkey CD11 subunit in the Vero cells? Although 
Vero cells are derived from the kidneys of African green monkeys, these cells 
have been documented to be devoid of any monkey CD11/CD18 expression on 
their surface.
Subsequently, attempts to rescue or augment the low expression of CD18 by 
transfecting the Vero cell clones with human CD11a recombinant vector as a full 
length bovine CD11a sequence had not yet been acquired. The Vero cell clones 
transfected with human CD11a subunit showed an increased transient 
expression of the chimeric heterodimer human CD11a/bovine CD18 48 hrs 
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following transfection as detected by immunostaining and confocal microscopy. 
The clones selected 48 hrs post-transfection for stable expression of human 
CD11a/bovine CD18 with GeneticinR and ZeocinR did not survive long enough in 
the selective media to be tested. The death of the clones in the selective media 
might have been due to the coupled toxic effect of the antibiotics. Another 
possibility might have been that some Vero cell clones may have not received 
the human CD11a recombinant vector cells, and would have ultimate died due to 
the toxicity conferred by the other antibiotic. 
The probable implications of LKT-sensitivity assessment conducted on low 
bovine-CD18 expressing Vero clones coupled with immunostaining and confocal 
microscopy results from the same Vero clones rescued with human CD11a 
subunit are as follows:
1) There was no real bovine CD18 surface expression on the Vero cell 
clones.
2) Bovine CD18 expression alone might not have been recognized by the 
LKT. Even if the CD18 expression was recognized, it was not sufficient for 
LKT-mediated cytolysis.
3) Expression of CD11 subunit with CD18 as a heterodimer is probably 
required for LKT binding and subsequent cytotoxicity. This further implies 
that the CD11 subunit might be directly or indirectly involved in the 
mediation of toxicity, but CD11 is necessary for the proper conformation 
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and recognition of the heterodimer by the LKT, for binding and following 
cytotoxicity.
4) Even though the LKT bound to bovine CD18, the probable inherent vitality 
of the Vero cells would have made them resistant to the cytolytic effects of 
the LKT.
The Vero clones were not tested any further and were frozen. For all the 
subsequent transfections, K562 cells were chosen for their non-adherent nature 
and the relative ease of testing them with flow cytometric analysis. Also, there 
was documented evidence of these cells being invoved in the recombinant 
expression of human CD11a/CD18 (Lally et al., 1997). As per expectation and 
the published literature, K562 cells transfected with the bovine CD18 subunit 
alone and stably selected with GeneticinR did not show any bovine CD18 using 
flow cytometry. By this time, successful generation of the full length coding 
sequence of bovine CD11a was accomplished. These non-bovine CD18 
expressing clones when rescued with bovine and human CD11a subunits 
exhibited transient expression of the heterodimer as detected by immunostaining 
and confocal microscopy. Whereas these results were promising, the transient 
expression technique did not reliably produce enough cells for the necessary 
downstream experiments of trypan blue dye exclusion test, LDH release assay or 
any other cell viability/cytotoxicity assays. 
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Therefore, in continuing attempts to generate stably expressing clones, the K562 
cells were co-transfected with bovine CD11a and CD18 as well as human CD11a 
and CD18 subunits as originally planned. The transient expression experiments 
consistently showed some expression of the expected heterodimers, whereas 
the generation of stable expressing clones still remained elusive. While it is
acknowledged that the stable expression of CD11a/CD18 by the co-transfected 
cells might not have been achieved due to their limited survival in the selection 
antibiotics, the low level of the transient heterodimeric expression was confusing. 
Since the co-transfected cells were propagated in antibiotic-free media and were 
tested for expression 48 hrs following transfection, there was no obvious
confounding factor(s) that would corroborate the low levels of transient 
CD11a/CD18 expression. The probable reasons may have been the differences 
in copy number of the recombinant vectors in the transfected cell, and/or the 
presence of a similar CMV promoter in both pcDNA3.1/Neo and pcDNA3.1/Zeo. 
CMV, being a strong promoter competes for driving gene expression. This 
means that the CMV promoters of pcDNA3.1/Neo and pcDNA3.1/Zeo would 
have competed with one another resulting in decreasing or completely shutting of 
each other’s capability to drive their specific gene expressions, and ultimately, 
the expression of the heterodimer.
To augment the transient expression of CD11a/CD18, pBUDCE4.1 (Catalog # 
V532-20, Invitrogen Inc.) was acquired. The pBudCE4.1 vector was specifically 
designed for the transient expression of two genes from a single plasmid in
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mammalian cells. Using pBudCE4.1 to generate transient mammalian expression 
cell lines would have ensured that there was an equivalent copy number of each 
gene in the transfected cell. This could have eliminated the variable expression 
due to differences in gene copy number and the presence of non-competing 
promotors. pBudCE4.1 had built-in expression cassettes with the following 
features: 
• The CMV promoter for high-level transcription of genes.
• The human EF-1α promoter for high-level expression of genes.
• The Sh ble (ZeoR) gene for efficient selection in mammalian cells with the 
selection agent ZeocinR.
• Two multiple cloning regions with different sets of restriction sites for the 
directional cloning of two genes.
When recombinant pBUDCE4.1 was being constructed, the process of 
generating bovine CD11a coding sequence was still incomplete. As a result, a 
human CD11a sequence was incorporated using HindIII and XbaI restriction 
sites into one of the multiple cloning regions and human CD11a expression was 
supposed to be driven by CMV promoter. Further, the same primer set that was 
designed for bovine CD18 earlier was used, except that instead of HindIII and 
XbaI, Csp45 I and Sfi I restriction sites were incorporated into the sense and 
antisense primers, respectively for directional cloning. The PCR generation of 
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bovine CD18 with upstream Csp45 I and downstream Sfi I went smoothly. 
Extreme difficulty in incorporating this newly generated gene into the other 
multiple cloning region of pBUDCe4.1 vector that already had human CD11a was 
encountered. Multiple efforts to accomplish this met with failure. 
As an alternate strategy, we tried to incorporate bovine CD18 first followed by 
human CD11a. All such efforts failed. Bovine CD18 apparently would not insert 
into pBUDCE4.1. The possibility of using restriction sites other than Csp45 I and 
Sfi I, or using HindIII and XbaI for bovine CD18 and some other restriction sites 
for human CD11a was explored. Due to limited options of the restriction sites 
present in the two multiple cloning sites, all such possibilities were thwarted. 
Therefore, no further attempts to generate a recombinant pBUDCE4.1 vector
were made. In the mean time, some more unsuccessful efforts and time was 
spent in generating stable CD11a/CD18 expressing clones using bovine and 
human CD11a and CD18 recombinant vectors. 
Future Directions: 
Following generation and testing of the K562 clones that stably express an 
immunobiologically active heterodimer (bovine CD11a/CD18, and/or human 
CD11a/bovine CD18), the extracellular domain of LKT-sensitive bovine CD18 
that mediates LKT binding and subsequent cytotoxicity can be swapped with the 
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extracellular domain of LKT-resistant human CD18. This chimeric CD18 subunit 
could again be expressed in K562 cells as a heterodimer with bovine or human 
CD11a. The expressed heterodimer would supposedly be immunologically 
active, i.e., its expression would be detectable by monoclonal antibodies, but 
would be resistant to the LKT-mediated cytolysis. The coding sequence of such 
LKT-resistant hybrid CD18 molecule could further be used to transfect bovine 
primordial stem cells in preparation for cloning an animal that is genetically-
resistant to the leukolytic action of M. hemolytica LKT. 
An alternative approach can be to resolve the crystal structure of the LKT-binding 
region on the extracellular domain of bovine CD18. This would enable elucidation 
of the pertinent amino acids or more precisely the nucleotides in the bovine
CD18 extracellular domain that might be involved in LKT binding. These amino 
acids or nucleotides can further be used as potential drug targets to prevent LKT 
binding, cytolysis and ultimately the animal mortality. 
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Scope and Method of Study: Mannheimia haemolytica is the etiological agent for 
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important virulence factor for this organism is leukotoxin (LKT), an 
exotoxin elaborated by M. haemolytica that destroys bovine immune cells 
sent to protect the host. The overall goal of this project was to characterize 
the interaction between LKT and the putative host cell receptor bovine 
CD18. Toward this goal, the strategy was to establish transfected cell lines 
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subcloning. Following generation of recombinant vectors, transfections 
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medium; however none of these exhibited surface CD18 expression. 
When tested with immunoblotting, 2 out of the 3 bovine CD18 expressing 
clones exhibited a band of the appropriate size for bovine CD18. 
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expressing clones; however this might have been due to the lack of 
specificity. Further, bovine CD18-expressing Vero clones were not 
sensitive to in vitro LKT challenge. When K562 cells were sequentially as 
well as co-transfected with different combinations of bovine and human 
CD11a and CD18, there was usually transient expression of the species 
as well as inter-species heterodimers as detected by immunostaining and 
confocal microscopy or flow cytometry. The major drawback of conducting 
transient expression studies in K562 cells was generating enough cells 
that could be simultaneously tested for heterodimeric expression and LKT 
sensitivity.
ADVISER’S APPROVAL:  Dr. Jerry Ritchey
